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Genetic studies indicated an association between neuropsychiatric diseases and a 
family of Ca2+ binding protein, Multiple C2 domain and transmembrane region 
protein (MCTP). MCTPs, including MCTP1 and MCTP2 in mammals contain 
two transmembrane regions (TMRs) and three C2 domains with high binding 
affinity for Ca2+. Expression and function of MCTP1 in the nervous system is still 
largely unknown. We investigated the expression profile and functional roles of 
MCTP1 in the nervous system.   
We cloned MCTP1 long isoform (MCTP1L) and short isoform (MCTP1S) from 
adult rat hippocampus messenger ribonucleic acid (mRNA) using polymerase 
chain reaction (PCR). The amino acid sequence of MCTP1 isoforms are highly 
conserved between human and rat. In situ hybridization histochemistry (ISH), 
double-immunofluorescence (IF) and immuno-histochemistry (IHC) revealed that 
MCTP1 is mainly expressed in neurons in rat brain, especially in brain regions 
which are involved in emotional functions, like prefrontal cortex (PFC), striatum, 
habenula, hippocampus, and amygdala. During brain development, MCTP1 is 
mainly detected in CP zone. Brain regions with earliest synaptogenesis show 
earliest MCTP1 expression. Real-time quantitative PCR also revealed a dramatic 
increase of MCTP1 expression when neurons are undergoing peak synaptogenesis. 
Outside the nervous system, IF staining also revealed expression of MCTP1 in 
granulocytes in blood, fibroblasts in fascia, and particular cells in spleen.   
At subcellular level, immunoelectron microscopy (IEM) and double IF revealed 
MCTP1 particularly concentrated in synaptic vesicles in mature neurons. In 
cultured PC12 cells, MCTP1S showed vesicular localization, while the truncated 
form of MCTP1 (MCTP1T) which lack TMRs showed diffused distribution. This 
observation indicated that the vesicular localization of MCTP1 depended on its 
TMRs. To characterize the identity of MCTP1 expressing vesicles in vitro, 
MCTP1S was either co-stained or co-transfected with various vesicular markers. 





marker Neuropeptide Y (NPY), but substantial co-localization with Vesicular 
acetylcholine transporter (VAChT) and Vesicle-associated membrane protein-2 
(Vamp2) in PC12 cells. In endocytic recycling pathway, MCTP1 showed 
substantial co-localization with Transferrin receptor (TfR), Rab5a and Rab11a.  
Functionally, overexpression of MCTP1S in PC12 cells significantly inhibited the 
endocytosis of Alexa 488-labeled transferrin and Vamp2-pHluorin-labeled 
secretory vesicles. However, MCTP1S overexpression had no significant effect 
on the glutamate release in SHSY5Y cells. In scratch assay, MCTP1L 
overexpression slowed cell migration. Finally, MCTP1 overexpression also 
protected PC12 cells from oxidative insult and glutamate toxicity, as indicated by 
reactive oxygen species (ROS) measurement.  
Taken together, these observations suggested that MCTP1 is an important 
regulator in endocytic recycling pathway and its dysfunction might affect various 



















1. Neurobiology of Emotion 
Emotion, as a subjective, conscious human perception, is associated with the 
physiological activity of the brain. The ability of brain to perceive environmental 
information, compute these information and then make a decision of action 
execution, depends on its fundamental units, neurons and the connections among 
neurons. Besides neurons, glia cells are also important for the functioning of brain.  
1.1 Cell types in the brain 
There are two main classes of cells in the brain: neurons and glia. The continuous 
stream of information from perceptions and/or memory to appropriate behavioral 
responses is processed by the brain using neurons and the connections between 
them. Glia cells might not be directly involved in information processing, but they 
are vital for the structure and functions of the brain in other aspects. Actually, 
there is 10 times more glia than neurons in the central nervous system of 
mammals. There are mainly three types of glial cells in the brain, i.e., astrocyte, 
oligodendrocyte and microglia. Astrocytes’ functions are quite diverse. They 
bring nutrients to neurons, form blood-brain barrier, and help to maintain the right 
potassium ion concentration in the extracellular space between neurons. In 
addition, astrocytes take up neurotransmitters from synaptic zones after release 
and thereby help regulate synaptic activities by removing transmitters. 
Oligodendrocytes insulate axons of neurons by forming a myelin sheath tightly 
winding around the axons of neurons. Microglia are the phagocytes of the central 
nervous system that arise from macrophages outside the nervous system. They are 
scavengers, removing debris after injury or neuronal death.  
1.2 Neuron 
The unique feature of brain is the hierarchy organization of various types of 
neurons. To form reliable connection with their partners and convey specific 
information directionally, neurons have adopted unique morphological and 
physiological features. A typical neuron is highly polarized and has three distinct 





receive information from other neurons, are analogous to the basal side of 
epithelium cells, and axons, which send information out, are analogous to the 
apical side of epithelium cells. There is no functional boundary between neuronal 
cell bodies and dendrites and thus most somatic organelles can also be found in 
dendrites. In sharp contrast, there is a physical and functional boundary between 
axon and neuronal soma, which is called axon hillock and localized on the 
emerging site of axon. As a result, numerous cytosolic organelles and proteins are 
excluded from axons. Axon terminal which contains numerous synaptic vesicles 
is also a specialized region which is unique to neurons. Another feature of neuron 
is that it is electrically excitable since its membrane potential can be significantly 
and quickly changed. Stimuli activate receptors localized on the receptive 
compartment of neurons, like dendrites, and generate a local input electrical 
signal. Integration of various input electrical signals is computed by neurons and 
axon hillock, the initial region of axon, decide whether to trigger an action 
potential. When an action potential is generated and reached the axon terminal, it 
will stimulate the release of neurotransmitters from synaptic vesicles.     
Human brain has various types of neurons. There is a wide variation in neuronal 
size, shape and electrochemical property. Classified by their functions, neurons 
can be grouped to sensory neurons, motor neurons, and interneurons. Classified 
by their morphology, neurons can be grouped into unipolar neuron, bipolar 
neuron, and multipolar neuron. In vertebrates, unipolar neurons exist in the 
autonomic nervous system and bipolar neurons are mostly utilized in sensory 
system. A typical multipolar neuron has numerous dendrites which have many 
branches and resemble a tree-like morphology, but no more than one axon which 
is much longer. This type of neurons is predominant in vertebrate nervous 
systems. Classified by neurotransmitter production, neurons can be cholinergic, 
GABAergic, glutamatergic, dopaminergic, serotonergic and so on. The functions 
of these neurons are specified by the type of neurotransmitter that they release. 
For example, spinal cord motor neurons use acetylcholine as neurotransmitter; 
dopaminergic neurons in substantia nigra are important for movement control and 





midline raphe nuclei of the brain stem, are involved in mood regulation. Besides 
the molecular differences among the various neurons, the specification and 
localization of various brain functions are also achieved by the precise and 
specific connections and anatomical circuits among these neurons.  
 1.3 Neurotransmission 
The point at which two neurons communicate is known as a synapse which is 
composed of a presynaptic terminal and a postsynaptic compartment. There are 
two forms of synaptic transmission, electrical and chemical. In comparison with 
electrical synapses, chemical synapses are more complex and capable of 
transmitting variable signals, so it is widely utilized in brain. Chemical synaptic 
transmission depends on the release of neurotransmitter from presynaptic 
terminals (Katz & Miledi, 1969; Bennett & McLachlan, 1972). Neurotransmitter 
is stored in synaptic vesicles (SV) which are clustered at the active zone in the 
presynaptic terminals. The arrival of an action potential opens voltage-gated Ca2+ 
channels at the active zone and lets Ca2+ enters the presynaptic terminal. The rise 
in intracellular Ca2+ concentration causes the vesicles to fuse with the presynaptic 
membrane and thereby release the neurotransmitter into the synaptic cleft, a 
process of exocytosis. The neurotransmitter then diffuses across the synaptic cleft 
and bind to their receptors on the postsynaptic membrane. This in turn activates 
the receptors on the postsynaptic membrane, leading to the opening or closing of 
ion channels and thus altering the membrane conductance and potential of the 
postsynaptic cell (Fig. 1-1). These serial steps which are termed as chemical 
synaptic transmission are fundamental for information processing in brain and are 






Figure 1-1. Chemical synapse schema  
A presynaptic action potential opens Ca2+ channels and the elevated Ca2+ 
concentration triggers the release of neurotransmitters which are packaged in SV. 
Released neurotransmitters bind to postsynaptic receptors and result in 
postsynaptic current (Pang & Sudhof, 2010). 
1.4 Brain anatomy and emotion 
Specific mental processes are represented locally in different brain regions. This 
is achieved by different types of neuronal cells forming precise anatomical 
circuits to carry out different actions. However, unlike sensory and motor system, 
it is quite hard to locate the brain anatomical basis of emotion. This is partly 
because the readout of emotion is hard to evaluate in animal models. By the 1930s, 
scientist began to observe evidences suggesting that there are certain brain regions 
that are particularly important for emotion processing. The evidence is cumulating 
and becoming more and more convincing. The brain regions which have been 
implicated in emotion include: mesolimbic system (rewarding system), amygdala, 





1.4.1 Mesolimbic system 
The mesolimbic pathway is one of the dopaminergic pathways in the brain. The 
pathway begins in the ventral tegmental area (VTA) of the midbrain and connects 
to the limbic system (amygdala and the hippocampus) and medial PFC via the 
nucleus accumbens which is a part of basal ganglia. This pathway is known to be 
involved in reward and motivation, and thus is heavily implicated in the 
neurobiological basis of various neuropsychiatric diseases.  
VTA is a group of neurons locating close to the midline on the ventral part of the 
midbrain. It is one of the origins of dopaminergic cell bodies. It receives 
glutamatergic afferents originated from a wide range of structures in brain. 
Studies have shown that the glutamatergic actions in the VTA are critical to drug 
abuse (Yang et al., 2010). 
Basal ganglia include the striatum (consisting of caudate nucleus, putamen, and 
nucleus accumbens) and globus pallidus. Inputs, originating from sensorymotor 
cortex, cingulate gyrus, amygdala, and VTA innervate neurons in striatum. The 
information will in turn be sent out from globus pallidus to mediodorsal thalamic 
nucleus and return back to premotor cortex and other motor associated areas in 
cortex. This cortical-basal ganglia-thalamus-cortical loop is fundamentally 
important for action selection and its dysfunction is indicated in numerous 
neurological diseases including schizophrenia, attention-deficit disorder, 
obsessive-compulsive disorder, and addictions. Within this loop, nucleus 
accumbens has gained lots of attention for its involvement in reward, addiction 
and fear. Major inputs to the nucleus accumbens include prefrontal association 
cortices, dopaminergic neurons located in the VTA, and basolateral amygdala. 
The output neurons of the nucleus accumbens send axon projections to the ventral 
pallidum. The ventral pallidum, in turn, projects to the mediodorsal nucleus of the 






Amygdala lies in the pole of the temporal lobe just below the cortex on the medial 
side. It receives inputs, especially sensory information, from various regions in 
the neocortex. Amygdala also receives monoaminergic inputs from midbrain 
structures, like VTA. Amygdala sent the information out through two major 
pathways. The first pathway projects to the septal nuclei and the hypothalamus. 
The second pathway innervates the dorsomedial nucleus of the thalamus, the 
prefrontal and entorhinal cortex and the brainstem. Surgery lesion of amygdala in 
both animal and human leads to a loss of fear and failure to recognize fear 
expression. However, more and more evidence has shown that amygdala is 
involved not only in fear related response but also other emotional information 
processing and it is indeed a central part of emotion regulation system.  
1.4.3 Prefrontal cortex 
The prefrontal cortex (PFC) is the anterior part of the frontal lobes of the brain. It 
receives inputs from mediodorsal nucleus of the thalamus and also interconnects 
with other brain regions which are involved in attention, cognition, and action. 
PFC also plays a crucial role in emotional regulation via an inhibitory connection 
to the amygdala (Davidson et al., 2000). In addition, patients with bilateral lesions 
of the ventromedial PFC have difficulties to anticipate future positive or negative 
consequences, but can anticipate rewards or punishments which are immediately 
available (Bechara et al., 1998).  
1.4.4 Habenula 
The habenula is a pair of small nuclei located above the thalamus and next to the 
midline. The habenula receives inputs from the basal ganglia (including striatum 
and globus pallidus) and the limbic system (septum) and sends outputs to 
midbrain (VTA and substantia nigra) and forebrain structures which contain 
dopaminergic neurons and to serotonergic neurons located in raphe nuclei. 
Acetylcholine, glutamate and substance P may be used as transmitters in this 





2. Neurobiology of psychiatric disease  
2.1 Overview of the psychiatric disease 
The abnormalities of brain regions involved in emotion regulation are associated 
with neuropsychiatric diseases including bipolar disorder (BD), schizophrenia, 
depression, and so on. Roughly one third of the world population had suffered 
from psychiatric diseases in sometimes of their life (2000). These 
neuropsychiatric diseases impair the daily lives of patients and pose a huge 
burden on society. 
Environmental factors and genetic factors interact together to give rise to the 
psychiatric diseases (Meyer-Lindenberg & Tost, 2012). Two of the most well 
studied environmental factors contributing to psychiatric diseases include social 
isolation and immune activation (Knafo & Plomin, 2006; Lederbogen et al., 2011; 
McAllister, 2014). The important role of immune activation in psychiatric 
diseases is also ascertained by the recent GWAS studies (2014) that the major 
histocompatibility complex (MHC) gene family, which are involved in the 
immune system and autoimmunity, is associated with schizophrenia. On the other 
hand, psychiatric diseases are highly heritable, which indicated that genetic 
factors play important role in the pathology of psychiatric diseases. For example, 
recent genetic study reports the duplications of chromosome 22q11.2 protect 
against schizophrenia, which is consistent with previous findings that deletion of 
this region is a genetic risk factor of schizophrenia (Karayiorgou et al., 1995; 
Lindsay et al., 1995; Rees et al., 2014). However, it should also bear in mind that 
psychiatric diseases are polygenic and each risk gene only plays a small role in 
the pathology.  
Dysfunction of synaptic transmission plays an important role in psychiatric 
diseases (van Spronsen & Hoogenraad, 2010). Studies of psychiatric patients’ 
postmortem reveal a changed expression of presynaptic markers, like Syp and 
SNAP-25 (Glantz & Lewis, 1997; Thompson et al., 1998; Fatemi et al., 2001), 





system, monoanimergic system, and glutamatergic system (van Spronsen & 
Hoogenraad, 2010). Take schizophrenia for example, a significant hypofunction 
of GABAergic system, hypofunction of glutamatergic system, and hyperfunction 
of dopaminergic system was found in the patients’ postmortem (Hashimoto et al., 
2003a; Hashimoto et al., 2003b; Lisman et al., 2008). Hypofunction of NMDA 
receptor is obvious in schizophrenia patients and the antagonist of NMDA 
receptor can reliably generate schizophrenia phenotype (Hashimoto et al., 2003a). 
The susceptibility genes in schizophrenia are also indicated in various synaptic 
transmission processes. For example, COMT, which located at chromosome 
22q11 and is the most prominent gene associated with schizophrenia, is involved 
in monoamine metabolism (Tunbridge et al., 2004). DISC1 can regulate synaptic 
transmission by binding with cAMP-specific PDEB/D and GSK-3 (Carlyle et al., 
2011). DISC1 also directly regulate NMDA receptors and DISC1 overexpression 
can enhances the glutamate release from the presynaptic terminals (Wei et al., 
2014). Dysbindin is expressed in both pre- and postsynaptic compartments 
(Numakawa et al., 2004; Talbot et al., 2004). Overexpression of Dysbindin in 
primary neurons increased glutamate release, possibly via regulating vesicle 
and/or neurotransmitter receptors trafficking (Numakawa et al., 2004). Some 
other genes associating with schizophrenia play important roles in 
neurotransmission via their effect on neuronal development. For instance, NRG1 
might affect synaptic transmission by affecting synaptogenesis or synaptic 
pruning (Falls, 2003).  NRG1 contains an EGF-like domain which interacts with 
ErbB-type tyrosine kinase receptor. The interaction of NRG1 with tyrosine kinase 
receptor initiates cellular signals which are important for neuronal migration, 
axon guidance, synaptogenesis, glial differentiation, and neuronal synaptic 
transmission (Falls, 2003). Table 1-1 summarized the involvement of the 







Table 1-1. Susceptibility genes in schizophrenia and their involvement in 
neurotransmission.  
Gene Full name Function Neurotransmission 
involved 
Reference 
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Glutamatergic (Corvin et 
al., 2007) 
DTNP1 Dysbindin Interacts with 
SNAP and 
synapsin 1  
Glutamatergic (Williams et 
al., 2005) 













Dopaminergic  (Li et al., 
1996) 





Glutamatergic  (Millar et al., 
2000) 
 
2.2 Neurobiology of bipolar disorder 
2.2.1 Clinical features and therapeutics 
BD is one type of neuropsychiatric disease which shares many features with 
schizophrenia and depression. About 2.4% of world population has had a BD 
diagnosis at some time in their lives (2000). BD is a neuropsychiatric disease 
which is characterized by repeating and alternate onset of depressive episode and 
manic episode. In the depressed phase, the patients may have low mood or 
sadness. In the manic phase, the patients may have poor temper control, very 
elevated mood, increased energy, or very easily irritated. Suicide is a very real 
risk during both mania and depression. Substance abuse is also very common 





This illness is hard to treat. At present, main treatments are to prevent self-injury 
and suicide, to help the patient function as well as possible between episodes, and 
to make the episodes less frequent and severe. Mood stabilizing medications are 
usually the first choice to treat BD. This kind of medicines includes Lithium and 
Valproic acid. Electroconvulsive therapy and trans-cranial magnetic stimulation 
can also be used to treat the manic or depressive phase of BD if the patients do 
not respond to medication. 
2.2.2 Neuropathology of BD  
Imaging studies, including functional magnetic resonance imaging (fMRI) and 
positron emission tomography (PET), have shown that the brains of people with 
BD differ from the brains of healthy individuals. The regions which are most 
commonly implicated in BD are PFC and amygdala. In BD patients, the most 
striking brain abnormality is a reduction in density or number of the glial cells and 
possibly in the size and density of neurons as well in PFC (Rajkowska et al., 
2001), and hence a reduced volume of PFC. Increases in amygdala volumes 
(Strakowski et al., 1999; Strakowski et al., 2000) is another anatomical feature of 
BD. In depressed BD patients and manic patients, reduced metabolism and 
activity in PFC (Baxter et al., 1989; Blumberg et al., 1999) and increased 
metabolism in amygdala are also found (Ketter et al., 2001). It may be speculated 
that the findings in bipolar patients of enlarged amygdala volumes and enhanced 
activity within the amygdala, together with reduced PFC volumes and metabolism, 
indicate an oversensitivity of emotional information identification (which is the 
function of amygdala), but an impaired effortful regulation of the subsequent 
emotional behavior (the function of PFC).  
Besides cell loss in brain, the imbalance in neurotransmission in brain's mood-
regulating system (Jones & Craddock, 2001) is also believed to be involved in the 
pathology of BD, as it is also implicated in other neuropsychological diseases 
(Dickman & Davis, 2009) . To date, the pathophysiology of BD has focused upon 





Pharmacological studies also show that manipulations of monoaminergic 
transmission are effective in the therapies of various neuropsychiatric diseases 
including BD. For example, The agonists of dopamine (DA), which is implicated  
in the neuronal circuitry of reward (Wightman & Robinson, 2002), appear to be 
effective antidepressants and are able to precipitate mania in some bipolar patients 
(Manji and Potter, 1997). Furthermore, increasing evidences show a presence of 
monoaminergic system abnormalities in BD. Genetic studies show that genetic 
variations of the enzymes which are involved in amine metabolism could result in 
susceptibility to bipolar symptom (Kirov et al., 1998; Serretti et al., 1998; 
Rotondo et al., 2002); postmortem studies also showed an increased 
norepinephrine (NE) turnover in the cortical and thalamic areas of BD patients 
(Young et al., 1994; Vawter et al., 2000) and PET study had reported the binding 
ability of 5-hydroxytryptamine (5-HT) 1A receptor is decreased in in various 
brain regions of BD patients (Drevets et al., 1999). 
2.2.3 Genetics in BD 
Although the causes of BD are multiple and complex, studies have suggested that 
gene variation can play an important role. It is found that BD occurs more often in 
relatives of people with this kind of disease. In contrast to schizophrenia, much 
fewer genes were identified for BD by positional cloning. However, recent studies 
increasingly suggest an overlapping of susceptible genes involved in both 
schizophrenia and BD (Hall et al., 2009). At least five independent datasets have 
indicated that variation at the D-amino acid oxidase activator (DAOA/G30) locus 
on chromosome 13q influences susceptibility to BD. This locus was also 
implicated in susceptibility to schizophrenia. DAOA is an activator of D-amino 
acid oxidase, which may degrade potential N-methyl-D-aspartate (NMDA) 
receptor activator. It has been suggested to have a role in mitochondrial function 
and dendritic arborization (Kvajo et al., 2008). Another candidate gene in BD 
pathology is brain derived neurotrophic factor (BDNF) (Green et al., 2006). 
BDNF is a member of the neurotrophin superfamily and important for the survival 





which is also subjected to substantial changes in response to stress and 
antidepressants. Genome-wide association and meta-analysis of BD in individuals 
conducted by Scott and his colleagues have found another 3 regions which are 
highly associated with the onset of BD (with association P ≈ 10-7). These three 
regions are, 1p31.1 (no known genes), 3p21 (>25 known genes), and 5q15 
(MCTP1) (Scott et al., 2009).  
Apart from genetics, many other factors, like developmental abnormalities of the 
brain structure, and the environmental stimulus, act together to produce the illness 
or increase risk of the onset of BD. 
3. Intracellular membrane Trafficking 
Eukaryotic cells have evolved an elaborate intracellular membrane-bound cargo 
trafficking system which allows bio-membrane and the enclosed contents to be 
transported from one subcellular compartment to another. Vesicular or tubular 
structures bud off from one membrane compartment and fuse with another, 
carrying membrane components and soluble molecules. These processes are very 
important for eukaryotic cells to release biosynthetic secretory materials to the 
extracellular matrix or to communicate with other cells (exocytosis), and to intake 
extracellular substance (endocytosis). The exocytosis leads outward from 
endoplasmic reticulum (ER), through Golgi apparatus, secretory vesicles and then 
arrives at cell surface; while the endocytosis leads inward from plasma membrane 
(PM), passing through either early endosome, late endosome, toward lysosome or 
other intracellular compartment. Besides this bidirectional traffic, intracellular 
membrane transport can also happen in side routes like, endocytic recycling 
which is carried out by recycling endosome (RE). To execute such complex and 
precise transport, the budding and fusion process of transport packages must be 
highly selective. This selectivity is made possible by the coherent cooperation 
among various molecules.   





Cargoes which are destined to the PM or secretion are packed into outward 
trafficking vesicles and transported from ER, through Golgi, along microtubules 
and arrive at PM. This outward trafficking pathway is responsible to deliver PM 
resident proteins such as receptors and channels onto PM and secreted proteins 
such as signaling molecules outside the cell. It also allows cell membrane 
expansion during cell growth and spreading. There are two types of outward 
trafficking, constitutive secretory pathway and regulated secretory pathway. Both 
constitutive secretory vesicles and regulated secretory vesicles are transported 
along microtubules to the site of release. In constitutive secretory pathway, 
transport vesicles destined for the PM normally leave the trans-Golgi network 
(TGN) in a steady stream and fuse with the PM once they arrive there. In 
regulatory secretory pathway, secretory substances are stored in secretory vesicles 
and released in a regulated manner. Secretory vesicles in regulatory secretory 
pathway fuse with the PM only when the cell receives an external signal, either 
chemical or physical. The external signal may activate receptors or ion channels 
on the PM, which in turn generate intracellular signals to facilitate the fusion of 
the secretory vesicles. The cytomatrix in localized PM segments is critical for the 
regulated exocytosis. This is why the regulated exocytosis can be restricted on a 
localized region of the cell. SV exocytosis is a typical example of regulated 
exocytosis.  
3.2 Endocytosis: Transport into the cell from the PM. 
The process that PM invaginates into intracellular space, pinches off and is 
transported into intracellular compartment is termed as endocytosis.  Receptors, 
extracellular fluid, and large particles such as microorganisms all enter cells 
through endocytosis. Actually, endocytosis is such a continuous process that 
typical fibroblasts can endocytose 1% of their PM per minute. Membrane 
component which is added into the PM by regulated exocytosis is also removed 
from the PM by endocytosis. Endocytosis can be divided into those that are 
Clathrin dependent and those that are Clathrin independent. Regardless of the 





where cargo can be routed either to the late endosomes and lysosomes for 
degradation or to the TGN or REs which carry the cargo back to the PM. By 
visualizing the uptaken molecules, the endosome compartments appear like 
heterogeneous vesicular/tubular structures extending from the PM to centrosome. 
The heterogeneous compartments of endosome can be differentiated from each 
other by their distinct spatial distribution, morphology features and specific 
molecular markers. For example, the early endosomes lie just beneath the PM, 
while the late endosomes are located near the nucleus and Golgi apparatus.  
3.3 Endocytic recycling 
When early endosomes migrate toward the cell interior, portions of the early 
endosomes also shed tubules or vesicles which return material back to the PM. 
This forms part of RE. Besides recycle the membrane back to its original domain, 
endosome recycling can also delivered the cargoes to a different membrane 
domain, which is called transcytosis. By visualizing the traffic of fluorophore 
labeled transferrin (Tf), which is constantly undergoing endocytosis and recycling 
between PM and cell interior, it is revealed that there are two intracellular 
recycling pathways, the fast and slow recycling pathway (Dunn & Maxfield, 
1992). In the fast recycling pathway, the internalized Tf return to the PM very 
shortly after they are internalized; while in the slow recycling pathway, Tf 
gradually accumulate in the juxtanuclear RE compartment and then return to PM 
through small trafficking vesicles. Most of the fast and peripheral recycling 
structures are tubule-like and located immediately below the PM. The 
juxtanuclear RE compartment surrounds the centriole but separates from Golgi 
stacks. RE trafficking is strictly regulated by various conditions. For example, in 
fat cells and muscle cells, the glucose transporters are stored in specialized REs 
and undergo active recycling only in response to hormone stimulation. (Grant & 
Donaldson, 2009).  







Figure 1-2. Schematic diagram to illustrate routes of intracellular membrane 
trafficking. 
Secretory vesicles leave Golgi apparatus and traffic to PM through either 
constitutive or regulatory secretion pathways. PM components and extracellular 
substances enter cells through early endosome. Endocytosed materials are sorted 
through sorting endosome to either RE to recycle back to PM or to lysosome for 
degradation. Recycling pathway includes both fast RE and slow RE which 
involves a juxtanuclear RE compartment. Routes leading from inside towards 
outside were indicated by blue arrowheads, while routs leading from PM towards 
inside the cell were indicated by red arrowheads.  
 
3.4 The molecular mechanisms of membrane trafficking  
3.4.1 GTPases 
Guanosine Triphosphatases (GTPases) are a group of important regulators in 
membrane trafficking (Mizuno-Yamasaki et al., 2012). A switch from GDP bond 
form to GTP bond form enables these GTPases to insert into lipid bilayer and 
recruits coat proteins to specific membrane domain. Arf/Sar GTPases are best 
known as regulators in cargo selection and the budding and formation of the 





Different Rab members have distinct subcellular localization features, as shown in 
Table 1-2. Generally, fusion among early endosome requires Rab5. Rapid 
recycling of the endocytosed materials back to cell surface requires Rab4. SV 
docking and fusion involves Rab3 (Sudhof, 2004). Conversion of early endosome 
to late endosome involves Rab7. Export of recycled material from perinuclear RE 
compartment back to cell surface requires Rab11. The working mechanisms of 
Rab proteins can be quite different. Some Rab proteins confine the fusion position 
by forming big matching complexes, while other Rab proteins restrict the 
movement of vesicles by interacting with cytoskeleton proteins (Stenmark, 2009).  
Table 1-2. Subcellular locations of some Rab proteins. 
PROTEIN ORGANELLE 
Rab1   
Rab2   
Rab3 
Rab4    
Rab5  
Rab6   
Rab7  
Rab8   
Rab9   
Rab11   
ER, Golgi complex 
cis Golgi network 
secretory vesicles and SV 
early endosomes 
early endosomes 
medial- and trans-Golgi network 
sorting endosomes, late endosomes 
basolateral secretory vesicles 
late endosome, trans-Golgi network 
RE 
 
3.4.2 Proteins involved in vesicle budding 
Coat proteins are a type of proteins which form a cage of proteins covering the 
cytosolic surface of the budding vesicles. They are essential for the formation of 





Clathrin, COPI, and COPII. Each coat protein is responsible for specific transport 
steps. For example, Clathrin is mostly found on endosomes formed from PM and 
vesicles budding from TGN. COPI and COPII are found on vesicles which are 
trafficking between ER and Golgi complex. Generally, COPII is responsible for 
anterograde transport and COPI is responsible for retrograde transport (Williams 
et al., 2005).  
Adaptor protein complexes (APs) are another group of proteins that are critical in 
vesicle budding. Classical APs include at least four types of APs, named as AP1, 
AP2, AP3 and AP4. They are multisubunit complexes which can selectively bind 
to specific membrane proteins and soluble proteins and ensure the selective 
sorting of different cargoes. The Clathrin dependent SV budding from PM is 
mediated by AP2. AP3 was found to play a role in endocytic trafficking (Simpson 
et al., 1996; Dell'Angelica et al., 1997) and is required in the SV biogenesis. 
AP180 is a neuron-specific adaptor protein enriched at synapses. It works together 
with AP2 to assemble Clathrin-coated vesicles.     
As a Clathrin-coated bud grows, soluble cytoplasmic proteins, including Dynamin, 
assemble as a ring around the neck of each bud. Subsequent pinching-off process 
requires Dynamin to recruit other proteins, which either distort the bilayer 
structure or change the lipid composition, into the neck of the bud and  help the 
membrane on the two side to fuse, seal, and form vesicles.   
3.4.3 SNAREs and Synaptotagmins 
How do the transport packages recognize their correct target membrane to fuse? It 
has been largely established that this recognition step is controlled mainly by 
Soluble N-ethyl-maleimide-sensitive fusion protein (NSF) attachment protein 
receptor complex (SNAREs). SNAREs are the ones executing the fusion process. 
The execution of the fusion process requires interaction between v-SNAREs 
(vesicle membrane SNAREs) and t-SNAREs (target membrane SNAREs). All 
SNARE proteins share a cytosolic domain consisting of 60-70 amino acids which 





complexes. When the trans-SNARE complexes form, the membranes of the 
transport vesicles and the target compartment are brought together to fuse. The 
specific interaction among SNAREs proteins determines the specificity of the 
vesicular fusion. A best studied working model of SNAREs is the membrane 
fusion machinery found on SV and presynaptic membrane (Ferro-Novick & Jahn, 
1994; Rothman, 1994). It is composed of Vesicle-associated membrane protein-2 
(Vamp2), Syntaxin and SNAP-25 (Jahn et al., 2003) (Fig. 1-3). The interaction 
among Vamp2, Syntaxin and SNAP-25 forms the trans-SNARE complex and 
causes the opposing membrane to fuse. However, this process is also impossible 
without the help of Synaptotagmin (Syt) (Chapman, 2002), a putative Ca2+ sensor, 




Figure 1-3. Core proteins involved in membrane fusion (Chapman, 2002).  
Synaptotagmin (Syt) and SNARE complex are shown. 
3.4.4 Cytomatrix proteins and other SV proteins 
Besides above mentioned proteins, some cytomatrix proteins in the microdomain 
of membrane fission and fusion are also important for the vesicle trafficking 





cytomatrix of active zone (AZ), a specialized microdomain under the presynaptic 
membrane, confines the site of SV exocytosis. In contrast, large dense core 
vesicles (LDCV) undergoes exocytosis at the PM lateral to the AZ, indicating that 
the compositions of the cytomatrix interacting with different types of secretory 
vesicles also vary (Thureson-Klein & Klein, 1990). Several well-known types of 
proteins in the cytomatrix of AZ include Munc13 (Brose et al., 1995), Rab3 
interacting molecules (RIM) (Wang et al., 1997), Piccolo/Basson (Cases-
Langhoff et al., 1996; tom Dieck et al., 1998) and cytoskeleton-associated 
proteins (Vega & Hsu, 2001). Munc13, RIM, and Piccolo/Basson all contain C2 
domains which can bind calcium. Besides, Munc13 also binds phospholipid and 
RIM binds Rab3. Piccolo/Basson may act as scaffold proteins in cytomatrix of 
AZ. Cortical cytoskeleton originating from the active zone membrane projects 
into axon terminal (Landis, 1988) and plays organizing roles in the AZ to harbor 
proteins used for exocytosis and endocytosis. Other important SV proteins and 
cytomatrix proteins in AZ include Munc18, which binds to Syntaxin to lock it 
from binding to other members of SNARE (Jahn et al., 2003), Synaptophysins 
(Syp), which bind directly to Vamp2 and prevent the interaction between Vamp2 
with other SNAREs (Johnston & Sudhof, 1990; Washbourne et al., 1995), and 
Synapsin, which is believed to be the mediator that connects SVs with 
cytoskeleton in the reserving pool (Hilfiker et al., 1999). 
All of the mentioned proteins work in concert to facilitate fusion between 
secretory vesicles and PM. Briefly, first, in priming and docking process, Rab and 
Rab-effectors (Rim and Rabphilins) assist nSec1/Munc18 to be dissociated from 
Syntaxin. This dissociation will in turn facilitate Syntaxin to bind with Vamp2 
and SNAP-25 (SNARE complex). Second, in fusion process, Ca2+ influx through 
Ca2+ channel or intracellular store triggers conformational change of the Ca2+ 
sensor, like Syt, and rapid zippering of SNARE complex, forcing vesicle 
membrane to fuse with PM (Sudhof, 2008; An & Zenisek, 2004).   





Discoveries in human genetic diseases reveal that the nervous system is one of the 
most severely affected systems when something goes wrong in intracellular 
membrane trafficking pathway. Intracellular membrane trafficking has evolved 
special features in nervous system and is extremely important for many 
fundamental physiological functions of neurons.   
3.5.1 Different types of secretory vesicles involved in neurotransmission  
Based on chemical identification and electrical microscopic observation, there are 
at least three types of secretory vesicles in presynaptic terminals. The first type is 
SVs, which release classical neurotransmitters, such as glutamate, γ-
Aminobutyric acid (GABA), glycine, ATP, and acetylcholine. SVs appear small 
and clear under electron microscope. Their release mediates fast point-to-point 
transmission, or wiring transmission (Sudhof, 2004). The second type of secretory 
vesicles is small dense-core vesicles (SDCV), which release monoaminergic 
neurotransmitters, like DA, serotonin, and noradrenaline (Brock & Cunnane, 1987; 
Stjarne, 2000). The third type is LDCV, which release neuropeptides (Salio et al., 
2006). The latter two types of secretory vesicles play important roles in volume 
transmission (Agnati et al., 1995). In fact, various types of secretory vesicles are 
found co-existing in most of the neurons (Salio et al., 2006). For different types of 
vesicles, the exocytosis-triggering stimuli, the kinetic of exocytosis, and the 
protein composition of the vesicle coat, can all be different. Even for the same 
type of vesicles, there can also be spontaneous exocytosis (Wasser & Kavalali, 
2009) or action potential triggered exocytosis. The complex neuronal secretory 
vesicle exocytosis is regulated by diverse molecular mechanisms and/or pathways.  
3.5.2 SV biogenesis  
The concept that the biogenesis of SVs in neurons utilizes the recycling pathway 
was proposed as early as 1970s (Ceccarelli et al., 1973; Heuser & Reese, 1973). 
This proposal is consistent with the fact that the neurotransmitters, which are 
stored in SVs, can be synthesized in cytoplasm and transported across the SV 





SV proteins are transported to the end of the axon by carriers that are larger than 
the mature SVs. Those tubulovesicular structures have been proved to be the same 
carriers which conduct constitutive transport from Golgi to PM (Nakata et al., 
1998). Actually this tubulovesicular morphology is frequently observed in carriers 
that carry membrane to the PM from various intracellular structures in many cell 
types (Hirschberg et al., 1998). The hypothesis that SVs are synthesized in the 
axonal terminal is also supported by the observation that some key protein 
component of the SV membrane are delivered to the end of axon by different 
carriers (Hirokawa, 1996). As summarized in many excellent reviews (Sudhof, 
1995; Cremona & De Camilli, 1997; Hannah et al., 1999), the donor membrane of 
SVs can either be RE or PM. After the exocytosis of the SVs, SV membrane 
proteins and lipids are sorted into a membrane microdomain [raft theory (Simons 
& Ikonen, 1997)] where they are internalized via endocytosis. New SVs are re-
formed from these endosome or larger RE which is formed by the fusion of many 
endosomes (Santos et al., 2009). Besides being generated by endosome, SVs can 
also be generated directly from PM, which means the endocytosed vesicles 
become SVs directly (Sudhof, 1995; Cremona & De Camilli, 1997). It has been 
shown that the formation of SVs from the active zone of the PM involves no 
membrane intermediates and the process of SV regeneration is fast, whereas the 
formation of SVs from the PM region outside the active zone is slow and involves 
membrane intermediates (Koenig & Ikeda, 1996). 
In fact, SV proteins, including Syp, Vamp2 and VAChT, are found to localize in 
endocytic recycling compartments when they are expressed in non-primary 
neurons (Johnston et al., 1989; Linstedt & Kelly, 1991). In fibroblast cells, Syp 
co-localize with TfR and undergo constitutive recycling between PM and early 
endosome, which also suggested that SVs in neuronal cells are evolved from a 
recycling pathway common to all cell types. In non-primary neuron cells, the 
biogenesis of synaptic like micro vesicles (SLMV) is studied mostly by observing 
the intracellular vesicular trafficking path of Syp. In PC12 cells, newly 
synthesized Syp leaves the TGN in constitutive secretory vesicles, arrive at PM in 





endocytosis for at least 1h before they enters the SLMV. Roughly 3hrs later, the 
distribution of Syp in PC12 cells can achieve a steady state. While, in steady state 
PC12 cells, Syp concentrates more in early endosomal membrane system than in 
SLMV, indicating that budding from early endosome is a rate limiting step in 
SLMV biogenesis.  
Various membrane proteins of SLMV may arrive at SLMV by different routes, 
which is also consistent with the observation that some key protein components of 
the SV membrane are delivered to the end of axon by different carriers (Hirokawa, 
1996). The internalization of these SV proteins from the PM and their targeting to 
SVs or SLMV are highly regulated (Feany et al., 1993). TfR is absent on SLMV 
in PC12 cells, which means that SLMV membrane proteins segregate from 
residential membrane proteins on RE in neuronal cells. Actually, once exposed to 
nerve growth factor (NGF), PC12 cells can differentiate into neuronal like 
morphology and contain two types of early endosomes. One type of the 
endosomes, which is localized in cell body, is TfR positive and has the same 
character of the somatodendritic early endosomes of neurons and the basolateral 
early endosomes of epithelial cells. The other type of the endosomes, which is 
found in the neurites of the differentiated PC12 cells, is TfR negative and 
corresponds to axonal early endosomes of neurons and the apical early endosomes 
of epithelial cells (Bonanomi et al., 2006).  
By contrast, the biogenesis of LDCV is quite different from the biogenesis of SVs. 
Similar to the secretory granules in non-neuronal regulated secretory cells (like 
endocrine and exocrine cells), LDCV forms in the TGN and transported to PM via 
regulated secretory pathway. Once fused with PM, the membrane component of 
LDCV can also be recycled if they are going to be utilized again. However, 
different from SV which can be resembled locally, the recycled membrane 
component of LDCV must be transported back to Golgi since the neuropeptide 
must be refilled there (Bauerfeind and Huttner, 1993; Hannah et al., 1999).  





Endocytic recycling is deeply involved in a wide range of cellular activities, like 
cell signaling, secretion, oxidative stress, cell migration and cell-cell fusion 
(Pajcini et al., 2008). Some of these processes are mediated by RE itself, while 
others are mediated by the biological functions of special protein cargoes of RE. 
For example, the endocytic recycling of E-cadherin, N-cadherin, and cell division 
cycle 42 (CDC42) are required for cell adhesion (Shaye et al., 2008) and neuronal 
migration (Kawauchi et al., 2010), processes that are inter related and important 
for organ morphogenesis. The regulated recycling and re-insertion of AMPA 
receptors on the postsynaptic membrane is also RE dependent and important for 
learning and memory (Brown et al., 2007). Besides, the recycling of Excitatory 
amino-acid transporters 3 (EAAT3), which is responsible for cysteine uptake and 
glutathione synthesis, is important for protecting neurons from reactive oxygen 
species (ROS) insult (Aoyama et al., 2006). 
Dysfunction of endocytic recycling is implicated in many neurological diseases, 
like Huntington’s disease (HD), Alzheimer’s disease (AD), autism, and so on 
(Howell et al., 2006). In HD, which is caused by the mutation of Huntingtin, 
patients suffer from neuronal cell death in striatum and cortex, and severe brain 
atrophy. Decreased Rab11 expression and Rab11 GEF activity on the membranes 
are found in Huntingtin null embryonic stem cells (Li & DiFiglia, 2012). The 
dysfunction of Rab11 results in a retardation in the delivery of RE cargoes to the 
PM (Li & DiFiglia, 2012). These cargoes, including TfR which is for the uptake 
of iron and EAAT3 which is for the uptake of cysteine to syntheses glutathione 
(Aoyama et al., 2006; Gonzalez et al., 2007), are important for cell metabolism 
and cell’s response to oxidative stress. Furthermore, researchers also found that 
expression of dominant active Rab11 (Rab11Q70L) can reduce oxidative stress 
and protect HD neurons from glutamate toxicity induced cell death (Li & DiFiglia, 
2012). These data indicated that drugs targeting Rab11 activity might be effective 
in HD treatment. RE pathway is also implicated in AD, which is a 
neurodegenerative disease caused by abnormal processing of amyloid precursor 
protein (APP) (Bertram et al., 2010) and Aβ generation. Presenilin is the core 





involved in the generation of Aβ. The recycling of Tf was also significantly 
delayed in Presenilin null embryonic stem cells (Zhang et al., 2006). In addition, 
Presenilin interact with Rab11 and localizes in RE (Lah & Levey, 2000), which 
also strengthen the argument that RE might be involved in the pathology of AD.  
The regulation of RE is also deeply involved in the pathology of autism, a brain 
developmental disorder with abnormal social communication and interaction. 
Interruption in the gene Rab11FIP5, which is a Rab11 effector and regulates 
transcytosis in brain (Bryant et al., 2010), is found in patient with a subtype of 
autism (Roohi et al., 2008). The dysfunction of RE may alter the PM expression 
of glutamate receptor, which in turn affect the brain function in autism patients 
(Strutz-Seebohm et al., 2006).  
4. Calcium binding proteins 
4.1 Calcium in cell biology  
4.1.1 Overview 
Inorganic ions, which include sodium, magnesium, chlorine, potassium, and 
calcium, account for 1% of total cell weight. They act together with 
macromolecules to execute various biological functions in living cells. Calcium is 
one of the most important inorganic ions in cells. It can either circulate in its 
unbound form or bind with proteins or anions. Calcium can serve as a second 
messenger which relays signals from cell surface to target molecules inside the 
cell. It can also act as a cofactor for many enzymes. Extracellular calcium is also 
important for maintaining the potential difference across excitable cell 
membranes. Within a typical cell, the intracellular concentration of ionized 
calcium is roughly 100 nM, but is subject to increases of 10 to 100 fold during 
various cellular functions. This increase of intracellular calcium concentration is 
caused by either an influx of extracellular calcium through calcium channels or a 
release from intracellular store, like ER and mitochondrion (Fig. 1-4). The 
increase of calcium concentration can either be global or focal. The changes of 





calcium binding proteins (Fig. 1-4) which in turn function in various important 
biological processes, like transcription activation, ER stress, neurotransmitter 
release in neurons, muscle contraction, and so on.  Moreover, a constant, slow 
leakage of calcium from the ER and/or Golgi cisternae could create a perpetual 
calcium gradient surrounding the organelles (Wahl et al., 1992). However, 
besides special cue theory, the physiological role of this intracellular calcium 




Figure 1-4. Cellular calcium homeostasis. 
Intracellular calcium concentration is tightly regulated by channels, pumps and 
exchangers. Increase of intracellular calcium concentration can be achieved by 
either calcium influx from extracellular space or calcium release from 
intracellular calcium store. ER and mitochondrial are the two main intracellular 
calcium stores. Calcium can bind to proteins in the cytoplasm (Syntichaki & 
Tavernarakis, 2003).  





Calcium is required in many intracellular membrane trafficking processes, like 
trafficking from ER to the Golgi apparatus (Beckers & Balch, 1989), early 
endosome fusion (Colombo et al., 1997), endosome-lysosome fusion (Luzio et al., 
2000; Pryor et al., 2000), and exocytosis (Pang & Sudhof, 2010). In these studies, 
membrane trafficking and fusion was inhibited by applying fast calcium chelator 
1,2-bis (2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid (BAPTA). It is also 
found that the source of the required calcium comes from the lumen of the fusion 
partners themselves (Hay, 2007). This means that the constitutive intracellular 
membrane trafficking and fusion happens with the transient increase of focally 
localized calcium in the absence of a global calcium increase.  
Calcium affects membrane trafficking and fusion through calcium sensing 
proteins. Calmodulin is one calcium sensing protein that received most attention 
in constitutive membrane transport. Upon binding with calcium, calmodulin can 
interact with Vamp2, which is involved in exo/endocytosis, and Syntaxin 13 and 
early endosome antigen1 (EEA1), which is important in early endosome fusion 
(Burgoyne & Clague, 2003). Another calcium sensing protein, Hrs, has also been 
proved to be important in endosome fusion. Hrs is a SNARE-mimetic protein 
which interacts with SNAP-25 through its coiled-coil domain. The binding 
between Hrs and SNAP-25 inhibit membrane fusion by blocking the binding 
between Vamp2 and SNAP-25/Syntaxin 13 complex. Once calcium is released 
from the lumen of endosome, Hrs dissociates with SNAP-25, which allows trans-
SNARE-complex formation and in turn endosome membrane fusion (Sun et al., 
2003). Calcium can also stabilize membrane location of coat-protein complex, 
COPI & II (Ahluwalia et al., 2001), which catalyze the budding of transport 
vesicles. However, the effect of stabilization of COPI & II on membrane by 
calcium can be either promotion or inhibition of membrane trafficking and fusion.  
The importance of calcium in the process of membrane trafficking and fusion is 
also supported by the discovery of the interaction between SNARE complex and 
vesicular localized calcium channels (Merz & Wickner, 2004).   





4.2.1 EF-hand proteins 
As mentioned above, part of the critical role of calcium in cells has to be mediated 
by calcium binding proteins. Hundreds of calcium binding proteins have been 
identified in human genome. The functions of calcium binding proteins range 
widely from calcium buffering, gene expression, membrane fusion, to signal 
transduction.  
More than 100 EF-hand-containing proteins have been described in human 
genome (Kawasaki et al., 1998).  These proteins turned out to be the most 
abundant intracellular Ca2+ binding proteins. The EF-hand domain, which is a 
helix-loop-helix Ca2+-binding motif, was first derived from Parvalbumin. This 
structure revealed six α-helices, designated A through F; thus, the spatial 
orientation of the fifth (E) and sixth (F) α-helix of Parvalbumin enclosing the 
calcium-binding loop resembles the ‘EF-hand’. Depending on their cellular 
functions, EF-hand containing proteins can be divided into two groups: calcium 
buffering proteins and calcium sensing proteins.  
4.2.1.1 Calcium buffering proteins in EF-hand protein family 
This subgroup of calcium binding proteins usually has a high Ca2+ binding 
affinity. Once binding with Ca2+, these proteins do not undergo a significant 
conformational change (Lewit-Bentley & Rety, 2000). The most well-known Ca2+ 
buffering proteins in the nervous system are Parvalbumin, Calbindin, and 
Calretinin.  
Parvalbumin is mostly expressed in the skeletal muscle and nervous system. It is a 
cytosolic protein with high Ca2+ binding affinity, and considered as an important 
Ca2+ buffering protein as the rate of Ca2+ decay is significantly slower after a fast 
stimulation of the muscle in Parvalbumin deficient mice (Schwaller et al., 1999). 
Calbindin is another brain enriched Ca2+ binding protein with a high binding 
affinity with Ca2+. It is also considered as a Ca2+ buffering protein but not a Ca2+ 
sensing protein since it can interact with its targets in the absence or presence of 





expressed in the nervous system. However, its function is not very clear. It is 
found to be expressed in the young maturing granule cells of the hippocampus but 
disappear when the neurons are mature, indicating that it may be involved in the 
maturation and migration of neurons and can serve as a differentiation marker.    
4.2.1.2 Calcium sensing proteins in EF-hand proteins family 
Calmodulin is the best known Ca2+ sensing proteins that can relay Ca2+ signals to 
lots of targets inside the cell. By binding of Ca2+, Calmodulin alters its 
conformation so that it can interact with its targets. These targets include a 
number of key enzymes which control various fundamental cellular activities such 
as intracellular motility, calcium transport, protein phosphorylation and 
dephosphorylation, cell cycle progression and gene expression. Calmodulin can 
participate in these processes by either activating these enzymes through direct 
interaction or being a direct subunit of the enzyme (Shenolikar et al., 1979).  
Centrins are Calmodulin-like proteins that interact with their targets in a Ca2+ 
dependent manner. They are associated with centriolar cylinders (Paoletti et al., 
1996) and their depletion leads to loss of microtubular organization (Baum et al., 
1986; Taillon et al., 1992), indicating their important roles in the organization and 
duplication of microtubules. 
S100 proteins constitute the largest family within the EF-hand proteins 
superfamily. Most of them show a cell- and tissue-specific expression, indicating 
specialized biological functions. They are small, acidic proteins that can either 
function as Ca2+ sensors within the cell or be secreted from the cell. They are 
implicated in several cellular processes, including cell proliferation, cell 
differentiation and cell migration. They are also found to be associated with 
neurodegenerative diseases and considered as valuable diagnostic candidates.  
Neuronal calcium sensors (NCS) are a group of EF-hand proteins that can be 
divided into five subfamilies (Burgoyne et al., 2004; Braunewell, 2005). Most 
NCS proteins are N-terminal myristoylated. The myristoyl group is sequestered in 





which permits reversible association of the protein with membranes (Burgoyne et 
al, 2004; Braunewell, 2005). These NCS function in phototransduction, 
neurotransmitter release, and the regulation of voltage gated potassium (Kv) 
channels.   
4.2.2 C2 domain containing proteins 
4.2.2.1 C2 domain 
Conventional protein kinase C (PKC) is a family of calcium binding proteins 
which are involved in signal transduction. Increase of calcium concentration 
activates conventional PKC which controls the function of other proteins by 
phosphorylating those proteins. Sequence comparison among proteins in PKC 
family reveals two constant sequences, which are termed C1 domain and C2 
domain, respectively.  
C2 domain consists about 120–130 amino acid residues. Crystal structure of C2 
domain reveals several stranded β sandwich and top loops containing four to five 
aspartic acid residues to bind Ca2+ (Ponting & Parker, 1996). Therefore, Ca2+-
binding properties of C2 domains can be in general predicted from sequence 
analysis and homology model building. C2 domains can be divided into two 
topological types (Nalefski & Falke, 1996). In type I C2 domains, like those of 
Syt-1, the β-strands are arranged in a linear manner and the C and N termini 
emerge at the top of the domain (Sutton et al., 1995). In contrast, in type II C2 
domains, like those of phospholipase C (Essen et al., 1996), the N terminus of the 
C2 domain is formed by β-strand 2 and the C terminus by β-strand 1, and the N 
and C termini emerge at the bottom of the C2 domain. Until now, nearly 200 
proteins containing C2 domain have been identified in human genome and the C2 
domain has become the second most common Ca2+ binding motif after the EF-
hand motif in vertebrate genome. Different from EF-hand motif, almost all 
calcium binding C2 domains can act as calcium sensor. Besides binding to Ca2+ , 
most C2 domains have been found to bind phospholipid in either Ca2+ -dependent 





second most abundant lipid binding domain behind the PH domain. It is 
demonstrated that Ca2+ binding can either change the electrostatic potential of the 
C2 domain or induce conformational changes of the C2 domain proteins, which in 
turn trigger the protein-membrane interaction. However, due to their structure 
diversities, C2 domains are quite different from each other in terms of their Ca2+ 
binding affinity, lipid selectivity and membrane binding ability. For example, 
some C2 domains of Syt-1 exhibit low intrinsic Ca2+ affinity which is subjected to 
a several times of increase in the presence of phospholipids (Ubach et al., 1998). 
In contrast, C2 domains of Rabphilin show a high intrinsic Ca2+ affinity even 
without the presence of phospholipids (Nalefski et al., 1994). Besides the Ca2+ 
and membrane binding properties, some of the C2 domains are even found to 
mediate protein-protein interaction, which is critical for the function of the host 
proteins.  
4.2.2.2 C2 domain proteins  
Proteins containing C2 domains can be roughly divided into three groups: single 
C2 domain proteins, multiple C2 domain proteins, and membrane anchored 
multiple C2 domain proteins. Most of the single C2 domain proteins are soluble 
proteins and involved in signaling transduction, like PKC and Nedd4.  
Multiple C2 domain proteins, which have no transmembrane region (TMR), are 
found to be involved in either membrane trafficking, like Copines (Tomsig & 
Creutz, 2000), DOC2, Munc13 and Rabphilin 3A, or cell signaling, like CAPRI, 
RASAL, and Inositolpolyphosphate 4-phosphatase (Cho & Stahelin, 2005). 
Proteins involved in membrane traffic may carry out their functions by interacting 
with SNAP-25, a member of the SNARE protein family, and/or Syt1, the Ca2+ 
sensor of the membrane fusion machinery (Dai et al., 2005).  
The membrane localization of proteins with multiple C2 domains but no TMR is 
mediated by their C2 domains. So, the subcellular localization of proteins with 
multiple C2 domains but no TMR is governed by the lipid selectivity of their C2 





affected by the residues on the surface of the Ca2+-binding loops. For example, 
the C2 domains of PKCα prefer phosphatidylserine rich membrane, while the C2 
domains of cPLA2α prefer phosphatidylcholine rich membrane (Clark et al., 1991; 
Nalefski et al., 1994; Stahelin et al., 2003). However, quite a lot of C2 domains 
show no lipid selectivity. For example, C2A domains of Syt bind anionic 
phospholipids via non-specific electrostatic interactions (Davletov & Sudhof, 
1993). Furthermore, some C2 domains translocate to cell membranes in linear 
response to cellular Ca2+ oscillations (Evans et al., 2001; Evans et al., 2006), 
which leads to linear response to the Ca2+ oscillation of the host protein. Actually, 
this is true for RASAL, a Ras GAP with tandem C2 domains, which associate to 
or dissociate from the membrane in linear response to cellular Ca2+ concentration 
changes (Liu et al., 2005). 
4.2.2.3 Proteins with multiple C2 domains and TMRs  
In human genome, there are only four protein families that contain both TMRs 
and multiple C2 domains. They are Syts, Ferlins, Multiple C2 domain and 
transmembrane proteins (MCTPs) (Shin et al., 2005) and extended Syts (E-Syt) 
(Min et al., 2007). They all have tandem cytosolic C2 domains, and are anchored 
to membrane by N- or C-terminal TMR. Membrane anchored multiple C2 domain 
proteins are found to play important roles in membrane trafficking and fusion 
processes. Representative ones include Syts involved in neurotransmitter release 
and Dysferlin involved in wound PM repair (Bansal et al., 2003; Bansal & 
Campbell, 2004). These calcium sensing proteins may involve in the membrane 
fusion process either by participating in the fusion machinery themselves, or by 
binding with members of such fusion machinery. 
4.2.2.3.1 Syt 
Syts are a group of proteins that consist of two cytosolic C2 domains and one N-
terminal TMR. To date, at least 16 members of this family have been identified in 
mammalian genome. Syt1 is the first identified Syts and abundantly expressed in 





expressed in both SVs and LDCVs. By using microinjection with anti-Syt1 
antibody (Ab) or recombinant fragments, researchers have found that Syt1 is 
crucial in post-docking exocytosis of SVs (Elferink et al., 1993; Fukuda et al., 
1995; Mikoshiba et al., 1995). In addition, Syt1 ablation in mice abolished the 
rapid exocytosis (Geppert et al., 1994). However, experiments in Syt1 null mutant 
Drosophila and C. elegans show a suppression of spontaneous SV fusion and 
affected vesicle docking, which is not found in mouse model. These findings 
indicate that the Syt members in mammalian cells may have specialized task 
assignment. They may function in different types of secretory vesicles, different 
stages of or modes of exocytosis (Littleton et al., 1994; Reist et al., 1998; 
Littleton et al., 1999). 
The distinct and specialized functions of different Syt members might result from 
the distinct Ca2+ binding properties of their C2 domains (Li et al., 1995). In 
general, vesicular Syts, like Syt1, Syt2 and Syt9, have lower Ca2+ binding affinity; 
while PM Syts, like Syt3 and Syt7, have a higher Ca2+ affinity (Sugita et al., 2001; 
Sugita et al., 2002). Among all the Syts, Syt1, Syt2 and Syt9 function as Ca2+ 
triggers for synaptic exocytosis in neuronal cells. They are expressed and function 
in distinct synapses. For example, Syt2, which triggers faster release, is utilized in 
neuromuscular junction; while Syt9, which triggers slower release, is primarily 
utilized in the reward pathway (Xu et al., 2007). The subcellular localization and 
function of other Syts are not fully investigated but some interesting discoveries 
are emerging. For example, Syt7 was found to regulate Ca2+-dependent lysosomal 
exocytosis in fibroblasts (Martinez et al., 2000; Jaiswal et al., 2004; Rao et al., 
2004). Evidence also shows that the effect of Syts on exocytosis can also be 
inhibitory, like Syt4, whose elevated expression can reduce exocytosis rate but 
not increase exocytosis (Littleton et al., 1999; Wang et al., 2001).  
Furthermore, Syt1 was also found to function in SV recycling (Jorgensen et al., 
1995) and the C2B domain of Syt1 is also found to interact with proteins involved 
in endocytosis (Haucke & De Camilli, 1999; Slepnev & De Camilli, 2000). This 





pathway. However, it is not clear whether Syts function in these two processes 
independently or cooperatively, since exocytosis and endocytosis are closely 
linked with each other. 
4.2.2.3.2 Extended Syt-like proteins (E-Syt)   
E-Syts contain one N-terminal TMR and five (in E-Syt1) or three (in E-Syt2 and 
E-Syt3) C2 domains in the C-terminal. The first C2 domain, C2A, which includes 
Ca2+ binding motif, is capable of Ca2+ dependent phospholipid binding. The C2C 
domains of E-Syt2 and E-Syt3 function as targeting motifs that localize these 
proteins into the PM independent of their TMR. In contrast, Myc-tagged E-Syt1 
locates to intracellular membranes but not PM (Min et al., 2007). The functions of 
E-Syts are still largely unknown. 
4.2.2.3.3 Ferlins 
There are six Ferlins in human genome. They are Dysferlin, Otoferlin, Myoferlin, 
Fer1L4, Fer1L5, and Fer1L6. These Ferlins possess five to seven C2 domains and 
a TMR in the C-terminal. The C2 domains of Ferlins share greater homology to 
the analogous C2 domains in other Ferlins, than to other C2 domains in the same 
protein (Han & Campbell, 2007). The C2A domains of Dysferlin and Myoferlin 
also show lipid binding capacity in a calcium-dependent manner (Davis et al., 
2002).  
Dysferlin shows ubiquitous expression with high abundance in skeletal muscle, 
heart and brain (Anderson et al., 1999). Subcellularly, dysferlin shows a PM 
(Anderson et al., 1999; Piccolo et al., 2000), intracellular vesicles (Bansal et al., 
2003), and endosomal vesicles (Evesson et al., 2010) localization in healthy 
skeletal muscle, but more cytoplasmic localization in dystrophic muscle (Piccolo 
et al., 2000). Dysferlin was found to be involved in membrane repair, cell 
adhesion via regulating intracellular vesicle trafficking and recycling. Mutations 
in Dysferlin cause an autosomal recessive form of muscular dystrophy (Bashir et 
al., 1998; Liu et al., 1998) which was proposed to be related with a defect in the 





Dysferlin was also found to result in a deficit in cell adhesion and angiogenesis 
via regulation of platelet/endothelial cell adhesion molecule (PECAM) trafficking 
in endothelial cells (Sharma et al., 2010).  
Myoferlin also shows ubiquitous expression with high abundance in skeletal 
muscle. It is also found to be involved in intracellular membrane trafficking and a 
number of its interaction partners are mediators in intracellular membrane 
transport (Demonbreun et al., 2010; Demonbreun et al., 2011). For instance, 
knockdown of Myoferlin in COS-7 cells was found to decrease Clathrin- and 
Caveolin-dependent endocytosis (Bernatchez et al., 2009).   
Otoferlin is expressed in the brain, vestibular system and cochlea (Yasunaga et al., 
1999). Otoferlin is localized to the presynaptic membrane of the inner hair cells of 
the cochlea (Roux et al., 2006). Mutations in Otoferlin cause an autosomal 
recessive form of non-syndromic deafness (Yasunaga et al., 1999) and Otoferlin-
null mice are profoundly deaf. Biochemical and physiological evidence shows an 
involvement of Otoferlin in calcium-activated exocytosis at the ribbon synapse of 
cochlear inner hair cells (Roux et al., 2006; Dulon et al., 2009; Beurg et al., 2010; 
Johnson & Chapman, 2010). It is found that Otoferlin can bind to Syntaxin-1A 
and SNAP-25 in a Ca2+ dependent manner (Ramakrishnan et al., 2009; Johnson & 
Chapman, 2010). Five of the six Otoferlin C2 domains exhibit calcium-sensitive 
lipid binding. Recent evidence also shows an involvement of Otoferlin in SV 
recycling (Pangrsic et al., 2010). It is found that mutation of Otoferlin results in 
reduced numbers of SVs in cochlear inner hair cells, a reduced second phase of 
prolonged exocytosis, and a decreased capacity to sustain synaptic transmission 
under intensive stimulus. These findings implicate defective replenishment of SVs 
in Otoferlin mutant neurons.   
Studies on Fer1L5 also point to its role in endocytic recycling. Fer1L5 is 
expressed in nascent myotubes and interacts with endocytic recycling proteins, 
carboxy-terminal epidermal growth factor receptor substrate 15 homology 





2008; Posey et al., 2011). It is reported that EHD2 is required for Fer1L5 to target 
to the PM, which impairs myoblast fusion (Posey et al., 2011). 
4.2.2.3.4 Multiple C2 domain and transmembrane region proteins (MCTPs) 
Multiple C2 domain and transmembrane region proteins (MCTPs) share many 
structural similarities with Syts and Ferlins. MCTPs (including MCTP1 and 
MCTP2 in mammals) contain three C2 domains, named as C2A, C2B, and C2C, 
and two TMRs near the C-terminus (Shin et al., 2005). All three C2 domains of 
MCTPs belong to type II topology. MCTPs are highly conserved among different 
species. The domains showing the highest degree of conservation is the C2C 
domain and followed by the second TMR, which means a crucial role of these 
domains in the function of MCTPs (Shin et al., 2005). It has been characterized 
that the TMRs of MCTP can anchor to intracellular vesicular structures and the 
C2 domains of MCTP have high binding affinity with Ca2+ (Shin et al., 2005). 
However, no phospholipid binding ability was detected for C2A and C2B 
domains of MCTPs; while C2C domain of MCTP1 shows a weak phospholipid 
binding ability (Shin et al., 2005). 
Ablation of the Mctp analogue in C. elegans can cause early embryonic lethality, 
which indicated an essential role of this protein family (Maeda et al., 2001). 
However, its function in mammals is essentially unknown. Both MCTP1 and 
MCTP2 are widely expressed in mammalian tissues. However, MCTP1 is 
especially enriched in skeleton muscle and secondly enriched in heart; while 
MCTP2 is enriched in heart and testis (Shin et al., 2005). It is also reported in 
previous study that, in taste buds, rat MCTP1 is expressed only in sweet and bitter 
sensing cells, but not in sour and salt sensing cells (Moyer et al., 2009), which 
means a cell type-specific rather than universal function of MCTP1. The 
expression of MCTP1 and Mctp2 in brain is relatively low according to Shin’s 
western result. However, more and more evidence shows involvements of 
MCTP1 and MCTP2 in neuropsychiatric diseases. A genome-wide association 
analysis has shown association of an MCTP1 single-nucleotide polymorphism 





suggested a relationship between an MCTP2 gene SNP and susceptibility to 
schizophrenia (Djurovic et al., 2009). Moreover, genome scan analyses have 
revealed that MCTP2 and eight other genes at chromosome region 15q25-26 
showed the strongest linkage to recurrent early-onset major depression (Verma et 
al., 2008). These findings raised the possibility that MCTP might be involved in 
the Ca2+ regulated membrane trafficking and fusion processes and thus regulate 
brain functions. Besides, structural/functional abnormality of the MCTP 
genes/proteins might also contribute to pathology of neuropsychiatric diseases. 
However, whether MCTP is expressed and functional in brain is still under debate 
(Shin et al., 2005). The structural relationship among different calcium binding 
proteins is summarized in Figure 1-5.   
 
Figure 1-5. Schematic diagram illustrates the structure relationship among 
different Ca2+ binding proteins. 
5. The objectives of the current study 
The current study aims to investigate the expression pattern and the biological 





(1) The expression of MCTP1 messenger ribonucleic acid (mRNA) and protein in 
rat brain, 
(2) The subcellular localization of MCTP1 in neurons and PC12 cells 
(neuroendocrine cell line), 
(3) The functional roles of MCTP1 in the nervous system. 
A sound understanding of the expression and functions of MCTP1 in the nervous 
system is an important step towards a better comprehension of its possible 
involvement in the pathology of BD and other mood disorders, and a more 
complete picture about the regulation of synaptic/secretory vesicle biogenesis or 
recycling.  
 


















All chemicals used in this study are commercially available. Detailed information 
of these chemicals is given in the Table 2-1.  
Table 2-1. Chemicals used in the present study.  
Chemicals Suppliers 
40% acrylamide Bio-Rad (Hercules, CA) 
Agarose Invitrogen (Carlsbad, CA) 
Agar Sigma (St. Louis, MO) 
Ammonium persulfate (APS) Bio-Rad 
Ampicillium sodium Sigma 
Bromo-chloro-indolyl-galactophyranoside (X-gal) Bio-Rad 
Bromophenol blue Sigma 
Bovine serum albumin (BSA) Sigma 
4',6-diamidino-2-phenylindole (DAPI) Sigma 
1,4-Dithiothreitol (DTT) Invitrogen 
DNase I Invitrogen 
Ethanol  Merck 
EDTA  Merck 
Fetal bovine serum (FBS) Invitrogen 















Isopropyl β-D-1-thiogalactopyranoside (IPTG) Invitrogen 
1,2-Isopropanol Merck (Darmstadt, 
Germany) 
Kanamycin sulfate Sigma 




Poly-D-Lysin (PDL) Sigma 
Ponceau S Sigma 
Potassium chloride (KCl) Merck 
Sodium chloride (NaCl) Merck 
Sodium Dihydrogen phosphate, monohydrate 
(NaH2PO4) 
Merck  
Sodium dodecyl sulfate (SDS) Bio-Rad 
Tris base Sigma 
Trypsin Sigma 
Tween  20 Bio-Rad 





Yeast extract Sigma 
 
2. Experimental animals 
All animal uses in this study were approved by the Institutional Animal Care and 
Use Committee at the National University of Singapore. For mRNA extraction, 
protein extraction and histology, male Wistar rats aged 10 to 14 weeks and 
weighing 160-240 grams were used. For primary neuron culture, pregnant female 




wistar rats with E18 fetus were used. Efforts were made to minimize suffering and 
the number of animals used.  
3. Antibodies 
Primary and secondary antibodies used in present study are listed below. Details 
of the dilution in different applications were given in Table 2-2.  
Table 2-2. Antibodies used in present study.  




Rabbit anti-MCTP1 1:400 1:100 Home made 
Mouse anti-TfR  1: 500 Invitrogen(13-6800) 
Mouse anti-Syp  1:400 Sigma (S 5768) 
Mouse anti-OX42  1:50 AbD Serotec 
Mouse anti-β-Actin 1:5000  Sigma  
Mouse anti-glial fibrillary acidic protein 
(GFAP) 
 1:1000 Milipore 
Rabbit anti-green fluorescent protein 
(GFP) 
1:1000 1:2000 Abcam (ab6556) 
Mouse anti-Neurofilament (NF) 200  1:1000 Sigma 
Mouse anti-Map2  1:500 Milipore 
Mouse anti-β3 tubulin  1:200 Cell signaling 
Mouse anti-2’, 3’-cyclic nucleotide-3’-
phosphodiesterase (CNPase) 
 1:4000 Millipore 
Mouse anti-hemagglutinin (HA) 1:1000 1:1000 Sigma (H3663) 
Rabbit anti-HA 1:1000 1:1000 Millipore 
Mouse anti-GluR2  1:500 Millipore 
Alexa Fluor 568/488 goat anti-rabbit IgG   1:400 Invitrogen 
Alexa Fluor 568/488 goat anti-mouse IgG  1:400 Invitrogen 
Rabbit anti-Flag  1:200 Sigma 





4. RNA isolation, reverse transcription, polymerase chain reaction (PCR), 
and bioinformatics  
Total RNA, from either rat tissue or cultured cells, was extracted using RNeasy 
RNA isolation kit (QIAGEN) according to manufacturer's instructions. RNA 
quality and quantity were assessed by both NanoDrop (ND-3300, NanoDrop 
technologies, USA) and agarose gel electrophoresis. DNase I (Invitrogen) was 
used to remove trace genomic DNA contamination.  
Synthesis of first-strand complementary DNA (cDNA) from purified total RNA 
was carried out by using SuperScript III First Strand Synthesis System (Invitrogen) 
according to manufacturer’s instructions. For real-time quantitative PCR (qPCR), 
equal amount of total RNA from different samples were used for cDNA synthesis.   
The synthesized first-strand cDNA of rat hippocampus was probed and amplified 
for Mctp1 cDNA fragments using PCR. GoTaq@ Flexi DNA polymerase 
(Promega) was used to detect the expression of Mctp1 mRNA isoforms. For 
cloning, Platinum Taq DNA Polymerase High Fidelity (Invitrogen) was used to 
amplify full length Mctp1 cDNA with high fidelity. The PCR products were 
purified and sequenced with BigDye terminator v3.1 cycle sequencing kit (ABI, 
USA) according to manufacturer’s instructions.  
To quantify the relative expression level of rat Mctp1 mRNA, real-time qPCR 
was performed. QuantiTect SYBR Green PCR Master Mix Kit (Qiagen) and 
Roche LightCycler System (Roche, Indianapolis, IN, USA) were used in qPCR. 
Details of the primers used in qPCR were listed in Table 2-3. The real-time qPCR 
reaction mix was prepared according to the table below:  
Component Volume (µl) Final concentration 
2× QuantiTect SYBR Green PCR Master 
Mix 
5 1X 
Forward Primer 0.5 0.5µM 




Reverse Primer 0.5 0.5µM 
Template cDNA 1  
Nuclease free water 3  
Total reaction volume 10 
 
The reaction mixture was dispensed into lightcycler capillaries (Roche) by a brief 
centrifugation (less than 2000rpm). The resulting capillaries were loaded into 
carousel of the lightCycler 2.0 machine and subjected to the following 
thermocyclic program:  
Step Temperature Time Ramp rate Program 










94°C (Denature) 15 sec 20 °C/S  
60°C (Annealing) 25 sec 20 °C/S  
72°C (Extension) 20 sec 20 °C/S Quantification 
45 cycles    
95 °C 0 sec 20 °C/S  
65 °C 15 sec 20 °C/S  
95 °C 0 sec 0.1 °C/S Melting 
Curve 
40 °C 30 sec 20 °C/S None 
 
The relative expression level of mRNA was indicated by fold change which was 
calculated as 2-ΔΔCt (Livak & Schmittgen, 2001). Threshold cycle (Ct) value is the 
cycle number, at which the fluorescent signal of SYBR in the sample first 
becomes exponential, mirroring the amplification copy number of the gene. The 
equation for calculating ΔΔCt can be summarized as: ΔΔCt = [sample1 (CtMCTP1 - 
CtGAPDH)] – [sample2 (CtMCTP1 - CtGAPDH)]. Sample1 refers to cDNA from DIV4 
or DIV13 primary neurons, and sample 2 cDNA from DIV1. 




Bioinformatics analyses were performed to predict the structure of rat Mctp1 gene 
and design the primers for rat Mctp1 cDNA cloning. The cDNA sequences of 
human MCTP1L and/or MCTP1S were blasted against rat genome (all assemblies) 
to search potential exons of rat Mctp1 gene. Potential exons were further 
confirmed by searching in rat expressed sequence tags (EST) database. Primers 
were then designed using online free software Primer3 to span different exons to 
identify mRNA isoforms of rat Mctp1. Primers used in the present study are listed 
in Table 2-3. Protein homology comparison was performed using blastp 
algorithm on NCBI website. MCTP1 3D structure prediction was carried out by 
submitting the amino acid sequence of MCTP1 to ESyPred3D online server 
(http://www.unamur.be/sciences/biologie/urbm/bioinfo/esypred/). A PDB file is 
generated by ESyPred3D prediction. The PDB file can be viewed by Swiss PDB 
viewer (spdbv.exe) to display various 3D features of the protein, like secondary 
structure, C2 signature residues and N-myristoylation site.   
 




Table 2-3. Primers used in present study. 





































Mctp1S cDNA cloning 
Mctp1S cDNA cloning  
Mctp1S cDNA cloning 
Mctp1S cDNA cloning 
Mctp1S cDNA cloning 
Mctp1S cDNA cloning 
Mctp1S cDNA cloning 
Mctp1S cDNA cloning 
Mctp1L cDNA cloning 
Mctp1L cDNA cloning 
Mctp1L ORF construct 








5. Cloning and construction of plasmids  
Rat Mctp1 cDNA fragments were amplified by PCR. The PCR products were 
ligated into pGEM-T Easy Vector (Promega) using T4 ligase (Promega) 
according to the manufacturer’s instruction. DH5α competent cells were 
transformed by the ligation products, and plated on LB/x-gal/IPTG selection 
plates. White colonies were selected and successful insertion was verified by 
restriction enzyme digestion. Briefly, a volume of 20μl reaction system containing 
0.5μg template DNA, 5U restriction enzyme (Promega), 2μl 10X reaction buffer, 




2μg BSA and deionized water was set up. The digestion was then performed in 
37ºC for 2 hours.  For mammalian expression plasmids construction, ORF of rat 
MCTP1S and MCTP1L were cloned in between BamHI and KpnI sites of pXJ40-
HA vector (Manser et al., 1997) respectively (HA-MCTP1S, HA-MCTP1L). ORF 
of rat MCTP1S and MCTP1T were also cloned in between EcoRI and BamHI 
sites of pmCherry-C1 vector (Clonetech) to construct mCherry-MCTP1S and 
mCherry-MCTP1T mammalian expression plasmids.  
Plasmid Neuropeptide Y (NPY)-EGFP-N1 is a generous gift from Dr. Chen Peng 
(NTU, Singapore). Plasmid Vamp2-pHluorin is a generous gift from Dr. Gero 
Miesenboeck. Plasmids Rab5-EGFP and Peroxisome-GFP are generous gifts from 
Dr. Niles Gauthier (MBI, NUS, Singapore). Plasmid Rab11-EGFP is a generous 
gift from Dr. Neftali Flores-Rodriguez (MBI, NUS, Singapore). Plasmid VAChT-
EGFP is a generous gift from Dr. Y Peng Loh (NICHD, USA). 
All Plasmids for primary neuron transfection experiments were purified by using 
EndoFree Plasmid Maxi Kit (Qiagen). Other plasmids for mammalian cell line 
transfection were purified by NucleoBond Xtra Midi Kit (Macherey-Nagel, 
Germany).  
6. Purification and Specificity test of anti-MCTP1 polyclonal Ab 
The DNA fragments encoding amino acid residues 575 to 638 of MCTP1S were 
cloned into pET41a (Novagen) to produce glutathione-S-transferase (GST) tagged 
MCTP1c fusion protein. GST-MCTP1c was expressed in BL21 cells and purified 
by using Bulk and RediPack GST Purification modules (Amersham Pharmacia, 
Piscataway, NJ). Polyclonal Ab against GST-MCTP1c was developed in New 
Zealand white rabbits. Serum was collected after the 6th boost. Ab was affinity 
purified using GST-MCTP1c antigen immobilized on polyvinylidene difluoride 
(PVDF) membranes (PerkinElmer, Boston, MA). Briefly, the GST-MCTP1c 
recombinant protein was expressed in BL21 cells and extracted with RIPA buffer 
(described below). The cell lysate was separated by 9% sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to PVDF 




membranes. Membrane slices containing the recombinant protein bands were 
minced into small pieces and incubated with rabbit antiserum. Ab was then eluted 
by 100 mM Glycine (pH 2.5) from the PVDF membrane. The eluate was then 
neutralized by Tris-HCl (pH 8.5) and adsorbed by GST-attaching PVDF 
membranes to remove anti-GST antibodies.  
To test specificity of rabbit anti-MCTP1 polyclonal Ab, pre-adsorption 
experiment was also carried out. The purified rabbit anti-MCTP1 polyclonal Ab 
(1:400) was incubated with membrane slices containing the recombinant protein 
bands for overnight at 4°C to adsorb the specific Ab. The supernatant was then 
used for western blot to see if the originally detected MCTP1 band disappeared. 
7. Western Blot 
For western blot, total protein were extracted from either rat brain or transfected 
cells using RIPA buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1% NP-40, 
proteinase inhibitor cocktail (Pierce), 1 mM EDTA, 0.1% SDS, 1.0% 
deoxycholate]. The tissue or cell lysate was denatured by boiling briefly in SDS-
gel loading buffer, separated by 9% SDS-PAGE, and transferred to PVDF 
membrane. PVDF membranes were blocked in phosphate buffered saline (PBS) 
containing 0.05% Tween-20, 5% fat-free dry milk and 2% normal goat serum for 
1 h at room temperature, and then incubated with primary Ab at 4°C overnight. 
Then, membranes were washed in PBS with 0.05% Tween-20 buffer and 
incubated for 1hr with alkaline phosphatase (AP)-conjugated goat anti-mouse or 
anti-rabbit IgG (Millipore) at room temperature. Immunoblots were developed 
with CDP-star chemiluminescence reagent (Roche, Basel, Switzerland). 
8. In situ hybridization histochemistry (ISH), Immunohistochemistry (IHC) 
and immunoelectron microscopy (IEM) 
Adult Wister rats were perfused transcardially with 3% paraformaldehyde (plus 
0.025% glutaraldehyde for electron microscopy) in 0.1 M phosphate buffer (PB, 
pH 7.4). The brains and spinal cords were dissected and post fixed in the same 
fixative for 4 h at 4°C. After post-fixation, brains used for light microscopy were 




immersed in 30% sucrose in PB overnight at 4°C and sectioned with a cryostat; 
while brains used for electron microscopy were rinsed with PBS and sectioned 
with a vibratome.  
ISH, IHC, and IEM were conducted following protocols described previously 
(Zhang et al., 2005). For ISH, digoxigenin-labeled antisense and sense cRNA 
probes against nucleotides 810 to 1958 of the open reading frame (ORF) of 
MCTP1S were used. Hybridization was then carried out in hybridization buffer 
with probes (0.8µg/ml) at 62°C for overnight. For IHC and IEM, Primary 
antibodies used are: rabbit anti-MCTP1, mouse anti-NF 200, mouse anti-GFAP, 
mouse anti-CNPase and mouse anti-OX42. Alexa Fluor 488 goat anti-rabbit IgG, 
Alexa Fluor 568 goat anti-mouse IgG (in immunofluorescence), and biotin 
conjugated goat anti-rabbit IgG (Vector Laboratories, Burlingame, CA) (in 
immunoperoxidase histology (IHC-DAB) and IEM) were used as secondary 
antibodies.  
9. Cell culture  
9.1 PC12 cell line (ATCC® CRL-1721™) 
PC12 is a rat cell line derived from rat pheochromocytoma of adrenal medulla. 
PC12 cells were maintained at 37°C in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 7% heat inactivated horse serum and 8% FBS with 
no substance coating. For immunocytochemistry and total internal reflection 
fluorescence microscopy (TIRFM) observation, PC12 cells were cultured on glass 
coverslip coated with collagen type IV as described in manufacture’s instruction 
(Sigma-Aldrich, C5533). Briefly, autoclaved coverslips were cleaned with 
sterilized ddH2O and dried briefly. Then, 40-50 µl 0.25mg/ml collagen type IV, 
which is reconstituted in 0.25% acetic acid (pH: 4) and stored in 4°C, were 
applied per 13mm coverslip. This was followed by incubating the coverslips at 
37°C for 2hrs, aspirating and recycling collagen (can reuse 3 times), washing the 
coverslips with sterilized PBS for 3 times 10min each, rinsing with sterilized 
ddH2O once, air-drying the coated coverslip, and sterilizing under UV light for 30 




min. The coverslips were finally sealed with parafilm and stored at 4°C until use. 
In some experiment, PC12 cells were differentiated by incubating in DMEM 
supplemented with 1% FBS and 100ng/ml NGF (Invitrogen) for 2 days.  
9.2 SHSY5Y cell line (ATCC® CRL-2266™) 
SHSY5Y cell is a human neuroblastoma cell line. It releases glutamate and DA 
(Biedler et al., 1978).  SHSY5Y cells were cultured in DMEM containing 10% 
FBS at 37°C with no coating on culture devices.  
9.3 Primary Neuron Culture 
Primary neurons were isolated and cultured according to published literatures 
(Kaech & Banker, 2006). Isolated neurons were seeded either on PDL coated petri 
dish or PDL coated glass coverslip. 
9.3.1 Preparation of seeding substrate 
Glass coverslips were treated with 70% concentrated Nitric Acid for at least 18 
hours at room temperature. The coverslip was flipped to ensure both sides of the 
glass coverslip are treated. Acid treated coverslips were rinsed with ddH2O for 4 
hours and then rinsed in absolute ethanol to remove water. Glass coverslips were 
dried and autoclaved before use.   
The petri dish and nitric acid treated coverslip were coated with 0.1mg/ml or 
1mg/ml PDL respectively. Coating was carried out at RT, O/N. Coated petri 
dishes or coverslips were rinsed thoroughly with sterile water and dried for 2hrs. 
Culturing devices were equilibrated in seeding medium till neuron plating.  
9.3.2 Primary neuron isolation and culture 
Embryonic day18 female Wistar rats were euthanized with pentobarbital 
(150mg/kg). Uterus were removed and individual fetuses were freed to sterile 
petri dish filled with sterile dissection medium (DM, Hepes-buffered Hanks' 
balanced salt solution (HBSS) without calcium or magnesium) with antibiotics 
(Penicillin/ Streptomycin). Brains from fetuses were dissected into dishes filled 




with ice cold DM. The meninges were torn off. The cerebral cortical tissue was 
removed into another clean dish filled with DM, chopped into pieces and pipetted 
into one 15ml tube. The following procedures were then carried out: 
Add trypsin into DM to a final concentration of 0.25%. Incubate cortex pieces in 
DM with trypsin for 20 min, at 37°C, agitating slowly. Then, add DNase I to a 
final concentration of 0.05mg/ml. Incubate for another 10 min in 37°C.  Gently 
remove supernatant and leave the cortical tissue sitting in the bottom of the tube. 
Wash tissue pieces with 4 ml seeding medium (DMEM supplemented with 5% 
FBS plus antibiotics) to neutralize remaining enzyme. Let stand for 2 min at 37°C. 
Repeat this step once to allow residual trypsin to diffuse from the tissue. Aspirate 
the last wash medium and add 4ml ice-cold seeding medium containing 0.1mg/ml 
DNase I.  
Triturate brain tissue slices very gently with 1ml plastic pipetting tips first, and 
then with fire polished glass Pasteur pipette with reduced diameter, avoiding 
bubbles. Then filter the cells suspension with 70µm filter. Spin down cells at 80g, 
5 min and re-suspend them with seeding medium and count the cells.  
Seed cells on dishes or coverslips with the following density: 2 × 105 cells per 
well for 24-well-plate and 2 × 106 cells per well for 6-well-plate. Medium were 
changed 4 h after seeding the cells to feeding medium (Neurobasal containing 
Glutamax, B27, and antibiotic) and maintained in feeding medium for up to 21 
days. Feeding medium was changed every 2 to 3 days by half changing the 
medium. FUDR was added 5 days after seeding the cells to inhibit non-neuronal 
cell proliferation.  
10. Transfection of cultured cells with mammalian expression plasmids 
Three methods were used to transfect nucleic acid into mammalian cells in this 
study.  
Method 1: Transfect PC12 cells with mammalian expression plasmids by using 
Effectene transfection reagent (Qiagen). 




This method was used to transfect PC12 cells when imaging experiments were 
going to be carried out following transfection. PC12 cells were seeded with a 
density of 7 X 104 cells/2cm2. Cells were then transfected on Day2 using 
Effectene transfection reagent according to manufacturer’s instruction.   
Method 2: Transfect mammalian expression plasmids into primary neurons using 
lipofectamin2000 (Invitrogen). 
Three days after cell seeding, half change neuron feeding medium. On Day4, 
aspirate the culture medium and keep the medium in 4ºC. Add fresh feeding 
medium plus FBS (5% FBS, without antibiotics) into cultured neuron. Prepare 
lipofectamin2000/plasmids mixture in OPTI-MEM according to manufacturer’s 
instruction. For one well in 24-well plate, 3µl lipofectamin2000 and 1µg plasmid 
DNA were used. 4.5hrs after adding the lipo/DNA complex, change the medium 
back to the medium which is saved before transfection.    
Method 3: Neon transfection system (Invitrogen).  
Neon transfection system was used when high transfection efficiency was needed. 
Transfection process was conducted according to manufacturer’s instruction. 
Optimizations were done to find out the best parameters for each individual cell 
type to achieve the highest transfection efficiency and viability. For both PC12 
cells and SHSY5Y cells, cell density for electroshock is 1.5 × 105 cells per 10μl 
buffer R. 0.5µg to 0.8µg DNA plasmids were used to transfect 1.5 × 105 cells. 
Parameters of the electroporation for PC12 cells were 1350 volts, 20 ms pulse 
width, and 3 pulses. Parameters of the electroporation for SHSY5Y cells were 
1150 volts, 20 ms pulse width, and 3 pulses. Medium was changed 6 h after 
transfection to remove the dead cells.  
For primary neurons, cells were seeded on 0.1mg/ml PDL coated 6-well plate and 
cultured in 37ºC, 5% CO2 for 15 to 20 h. Then the cells were trypsinized down 
and subjected to electroporation. Parameters used are: 1350 volts, 20 ms pulse 
width, and 3 pulses to give the best transfection efficiency and cell viability.   





For immunocytochemistry staining to probe MCTP1 and Syp, cells were washed 
twice with PBS and then fixed and permeabilized in 100% methanol for 5 min at 
-20°C. For immunocytochemistry probing other antigens, cells were fixed with 3% 
paraformaldehyde (PFA) for 15 min at room temperature and permeabilized with 
0.3% Triton X-100 in PBS for 5 min at room temperature. Cells were then 
blocked with 6% normal goat serum (NGS) in PBS. Primary antibodies were 
applied for overnight incubation at 4°C. After washing for several times with 
washing buffer (PBS containing 0.05% Tween-20), cells were then incubated 
with Alexa Fluor conjugated secondary Ab at room temperature for 2 h. After 
several washes with washing buffer, samples were mounted and viewed. Images 
were acquired either by using a confocal microscope (Fluoview, OLYMPUS, 
Tokyo, Japan) or a fluorescence microscope (Nikon eclipse E600) equipped with 
a Leica digital camera (DC480).  
12. Stable cell line construction 
SHSY5Y cells (passage 2-3) were transfected with MCTP1S-mCherry using 
Neon transfection system as described earlier. Transfected cells were plated in 6-
well plate with a density of 4 × 105 cells per well. Cell density was monitored to 
avoid more than 50% confluence when doing selection. Cells were fed with non-
selective medium for 24 h before drug selection. Neomycin (1.1mg/ml) was used 
for drug selection. Feed cells with selective medium every another day for 2 
weeks before cell clones formed. Cell clones with positive red fluorescence 
expression were picked out with yellow tips and transferred to 96-well plate. 
Serial dilution was carried out to screen single cell formed clones. The positive 
clones were transferred from one well in 96 well plate into two wells in 24 well 
plate.  One is used for amplification of the clone; the other is used for expression 
checking to choose several high expression stable clones that were amplified by 
transferring the cells to 6 well plate, then T25 flask and finally into T75 flask. 
Cells were maintained in selective medium along the whole process.  Once the 
stable clone of cells were thawed, they were cultured without G418 for one 




passage and then cultured with G418 (half of the original concentration) 
containing medium for the following process.  
13. Glutamate release detection by Amplex Red kit 
Glutamate release from cultured SHSY5Y cells and MCTP1S overexpressing 
SHSY5Y cells was determined by Amplex red assay using Amplex Red kit 
(Invitrogen) according to manufacturer’s instruction. Briefly, cells were seeded in 
24 well plates until 80% confluent. Cells are washed several times with pre-
warmed PBS. Then, cells are incubated with 150 µl either low K+ or high K+ 
extracellular solutions (ECS, below) for 30 min at 37 ºC with gentle shaking. Low 
K+ ECS contains 140 mM NaCl, 5 mM KCl, 2.2 mM CaCl2, 0.5 mM MgCl2, and 
5.6 mM glucose in 15mM HEPES, pH 7.4. High K+ ECS solution contains 30 
mM NaCl, 115 mM KCl, 2.2 mM CaCl2, 0.5 mM MgCl2, and 5.6 mM glucose in 
15mM HEPES, pH 7.4. After incubation, ECS was collected into 1.5ml tubes and 
centrifuged at 9000×g for 3 min to remove cell debris. Cells were trypsinized 
down and cell numbers were counted for each well. The supernatant were 
removed to another tube and kept on ice for the following assay. Reaction buffer 
and 20µm glutamic acid served as negative and positive controls, respectively. A 
glutamic acid standard was also prepared. The concentration of the glutamic acid 
ranged from 0 to 20µM. A working solution of amplex Red reagent contains 0.25 
U/mL HRP, 0.08 U/mL l-glutamate oxidase, 0.5 U/mL l-glutamate–pyruvate 
transaminase, and 200μM alanine. Reactions are conducted by adding 50 µl 
sample and 50 µl amplex red working solution together in black bottom 96-well 
plates and incubating for 30 min at 37ºC, avoiding light. The fluorescence was 
measured in an infinite@200 microplate reader (TECAN, Switzerland) using 
excitation of 530 nm and emission detection at 590 nm, top read mode. The 
concentrations of glutamate in the samples were calculated from the fluorescence 
values according to the equation derived from the standard curve.     
14. Tf recycling assay 




PC12 Cells transfected with pmCherry-C1 control plasmid or mCherry-MCTP1S 
overexpression plasmid were plated on coverslip in 24-well plates with a density 
which can achieve 80% confluence by the time when experiment was carried out. 
Tf recycling assay was carried out 48hrs post transfection. Cells were pre-
incubated in serum-free DMEM medium for 2 h at 37°C before Tf recycling assay. 
Then the cells were incubated in serum-free DMEM with 5μg/ml Alexa Fluor 488 
labeled human Tf (Tf488) (Molecular Probe) for 30 min at 4°C and followed by a 
further incubation in 18°C for 1h. Cells were then rinsed by cold DMEM twice to 
remove un-bound Tf488. After washing, cells were incubated in serum free 
DMEM for 30 min at 18°C. Then the cells were incubated in DMEM containing 
10% FBS in 37°C. Incubation was stopped at various times and cells were washed 
by cold PBS and then either sent to flow cytometry or fixed by PFA for imaging 
by confocal microscopy.   
15. Total internal reflection fluorescence microscopy (TIRFM) imaging 
Forty eight hours after transfection, PC12 cells were observed under TIRF 
microscope. TIRFM imaging were conducted with an inverted microscope 
(Eclipse Ti-E, Nikon, Japan) coupled with motorized TIRF illumination unit and 
Apo TIRF 60 Oil objective. Vamp2-pHluorin fusion proteins were photo 
activated by 488 nm laser. MCherry-MCTP1S and mCherry-MCTP1T proteins 
were photo activated by 561 nm laser. Images were acquired using a fast cooled 
CCD camera controlled by NIS-Element software (Nikon, Japan) with 300 ms 
exposures at 2 Hz for 2 min. Cells were kept in humidified chamber with 5% CO2 
supply, at 37°C throughout the whole live imaging data acquisition process. 
16. Ab uptake 
Forty eight hours after being transfected with Vamp2-pHluorin together with 
either pXJ-HA or pXJ-HA-MCTP1S, PC12 cells were incubated for 15 min at 
37°C with the anti-GFP Ab (0.25µg/ml, ab6556, Abcam) in extra cellular buffer 
(5.6 mM KCl, 140 mM NaCl, 2.2 mM CaCl2, 0.5 mM MgCl2, 5.6 mM glucose, 
and 15 mM HEPES, pH 7.4) containing 5% FBS. Then, cells were washed with 




PBS at 4°C and fixed with 3% PFA. After intensive washing, cells were incubated 
with PBST-NGS containing 0.3% Triton X-100 and 6% NGS for 1 h at room 
temperature. Alexa Fluor 568 goat anti-rabbit IgG (1:400, Invitrogen) was applied 
to visualize internalized and PM bound Vamp2-pHluorin which was exposed to 
extracellular fluid during exocytosis within the 15 min Ab incubation period. 
17. Migration assay 
The scratch assay was used to measure cell migration in vitro. SHSY5Y cells 
were transfected with either HA-MCTP1L or Flag-JN141 plasmid using Neon 
transfection system. 24 h after transfection and seeding the cells, a scratch was 
made using p200 pipette tips on a cell monolayer. Images were captured 
immediately to record initial wound boundary. 24 h post scratch, cells were fixed 
and immuno-stained using mouse anti-HA and rabbit anti-Flag primary Ab. DAPI 
was used to stain the entire cell population. Immunofluorescence (IF) images 
were captured and analyzed to quantify the migration rates of the cells.  
18. ROS measurement 
PC12 cells were transfected with MCTP1S, MCTP1L, or JN141 (control) 
plasmids. For glutamate treatment, normal culture medium was switched to 
medium containing 10mM glutamate 24 h after the transfection. Cells were 
incubated in 10mM glutamate for 24 h and then subjected to ROS level 
measurement. DMEM (without phenol red) containing 10 µM cell-permeant 2',7'-
dichlorodihydrofluorescein diacetate (H2DCFDA) was added to the cell cultures 
for 35min at 37°C. Cells were washed once with PBS. The treated PC12 cells 
were collected by trypsinization and centrifugation. Cells were re-suspended in 
DMEM (with no phenol red and no FBS) and subjected to flow cytometry. The 
fluorescent excitation and emission of H2DCFDA are 488nm and 527nm, 
respectively. Mean fluorescence intensity (MFI) of single transfected cells 
represented ROS level. 
19. Image analysis 




Vesicle mobility in time-lapse live imaging was measured by using Imaris 
software (Bitplane, Inc.). Vesicles or tubules were identified by “Surface” 
detection based on local fluorescence intensity contrast. Moving objects were 
tracked using autoregression motion algorithm. Time mapped colored tracks were 
created and statistics of the objects and tracks was given by the software.  
The extent of colocalization between two fluorophores was quantified by Imaris 
software (Bitplane, Inc.). Raw images were corrected by subtracting the 
background fluorescence outside the cell. A mask channel was generated to 
exclude regions outside the cell. Pearson's cofficient in colocalized volume was 
calculated and taken as the extent of colocalization between the two fluorophores.  
In Ab uptake experiments, IF photomicrographs were analyzed using ImageJ to 
quantify the amount of membrane-bound Vamp2-pHluorin. A region of interest 
(ROI) was first defined by thresholding to outline the whole cell. A second ROI 
was then derived by shrinking the first ROI by 0.82 µm to define the intracellular 
space of the cell. The area between the first ROI and the second ROI was 
considered as PM. Area, mean optical density of the staining and integrated 
optical density of the staining of the regions were measured. The mean optical 
densities of the staining on PM were presented to indicate the amount of 
membrane bound Vamp2-pHluorin per unit area.  
Exocytosis events were identified and selected by visual inspection while playing 
TIRF movie stacks, based on marked fluorescence increase. Fluorescence 
intensity change of single exocytosis event was analyzed using NIS-Element 
software (Nikon, Japan). A 0.62 μm diameter circle ROI was positioned over the 
center of the fluorescent granule and the mean fluorescence intensity was 
measured over time. The fluorescence of the annulus with an outer diameter of 
1.6 μm was subtracted from the inner circle as local background. The decay time 
of single exocytosis event was calculated as the time duration between the 
fluorescence peak intensity and the point of the fluorescence decline back to 36.8% 
of the peak above the baseline.  




In scratch assay, we first defined non-migrated cells and migrated cells on images 
taken 24 h post scratch as following: the phase contrast images of the cell 
monolayer taken immediately after the scratch (0 h) were merged with the same 
field immunostainned images taken 24hrs post scratch. Two border lines were 
drawn on the immunostainned images according to 0hr phase contrast images. 
Cells remained on the original side of the border were considered as non-migrated 
cells, while cells moved to the region between the two border lines were 
considered as migrated cells. HA stained cells represented MCTP1L 
overexpressing cells, Flag stained cells represented JN141 overexpression cells, 
DAPI staining represent all cells. Cell number counting was done by using Imaris 
software (Bitplane, Inc.) The objects were identified by “Surface” detection based 
on local intensity contrast.   
20. Statistics 
Statistical analyses were carried out with GraphPad Prism Software (San Diego, 
CA). All values were provided as mean ± SEM. Statistical significance was 
determined by paired t test in flow cytometry and glutamate release experiments 
and by unpaired t test in others. P value of less than 0.05 was considered 
significant. The frequency distribution of the decay time of single exocytosis 
event was plotted as histogram with bin width of 0.5s except for the last bin. The 


















1. Expression profile of rat MCTP1 in tissues 
1.1 MCTP1 expression in the central nervous system (CNS) 
1.1.1 MCTP1 protein isoforms, gene structure and SNP rs17418283 
Full length human MCTP1 (hMCTP1) has a long isoform (NM_024717.4) and a 
short isoform (NM_001002796.2). The two differ only by a 5’-end 57-base 
fragment of the ORF of hMCTP1S mRNA being replaced by a 720-base fragment 
in the ORF of hMCTP1L mRNA, probably due to utilization of different 
promoters. Similar long and short isoforms of rat MCTP1 (MCTP1L and 
MCTP1S) were predicted from the rat genome sequence (Fig. 3-1A), and 
confirmed by RT-PCR (using adult rat brain cDNAs as templates) and sequencing 
(Fig. 3-1B). Analyses of the mRNA sequences against rat genome indicated that 
both isoforms are derived from 21 exons (1/1’-21, Fig. 3-1A). Apart from the two 
extra exons (between exon6 and exon7 of rat Mctp1) in hMCTP1, the overall 
organizations of rat and human MCTP1 genes are the same. Blast search of rat 
MCTP1 isoforms in the functional domain database reveals that both MCTP1L 
and MCTP1S contain three C2 domains and two TMRs (Fig. 3-1A).  
SNP rs17418283 of hMctp1 gene, which was found associated with bipolar 
disorder (Scott et al., 2009), is located in the intron just before exon18 
(corresponding to exon16 of rat Mctp1, Fig. 3-1A), which encodes the first TMR 
of MCTP1 and is a known hot point for alternative splicing (Shin et al, 2005). 
Searches in rat EST database also revealed the possible existence of a truncated 
form of rat MCTP1 (MCTP1T) (BF390564) devoid of TMRs, resulted from a 
stop codon immediately after exon15 (Fig. 3-1A).  
To further confirm MCTP1 expression in rat brain at the protein level, we 
generated a rabbit anti-MCTP1 polyclonal Ab using the region between the first 
TMR and the second TMR of MCTP1 as an antigen (amino acid residues 575 to 
638 of MCTP1S). This Ab detected a major band at 87 kD (Fig. 3-1C), which is 
consistent with the predicted molecular size of MCTP1S, in adult rat brain lysate. 





immunoreactive band disappeared specifically when the Ab was pre-adsorbed 
with MCTP1 antigen, but not with control GST antigen (Fig. 3-1C). Taken 
together, MCTP1 does express in adult rat brain both at mRNA and protein levels. 
 
Figure 3-1. MCTP1 is expressed in the rat brain.  
A, Comparison of exon organization in rat MCTP1 isoforms. The gray blocks 
represented individual exons of rat Mctp1 gene, and the asterisk located in the 
intron between exon15 and exon16 represented the corresponding position of SNP 
rs17418283 in hMCTP1. Functional domains, including three C2 domains and 
two TMRs, were aligned under the corresponding exons. B, PCR amplified Mctp1 
transcript fragments were separated and visualized on agrose gel. F1 denotes the 
first 5’-end fragment of MCTP1S, and F1’ the first 5’-end fragment of MCTP1L. 
C, Western bot showing specificity of the in-house made MCTP1 antibody and 
expression of MCTP1 protein in the rat brain. Brain lysate was loaded in both 
lanes, but the left lane was probed with MCTP1 antibody pre-adsorbed with GST-
MCTP1c antigen. The right lane was probed with GST-adsorbed MCTP1 
antibody.  
 
Rat Mctp1 gene shares a high sequence similarity with hMCTP1. Alignment 
between rat MCTP1 and hMCTP1 amino acid sequences revealed 90.5% 
identities between hMCTP1S and rat MCTP1S and 89% identities between 
hMCTP1L and rat MCTP1L (Fig. 3-2). It is also noticed that within each 





or are critical for secondary structure formation were 100% conserved between 
hMCTP1 and rat MCTP1 (Fig. 3-2). These results showed that rat brain do 
express a MCTP1 orthologue which consists of at least two splice isoforms that 
are evolutionarily conserved and may functionally differ from each other. 
 






Isoforms of rat MCTP1 (rMCTP1L and rMCTP1S) and human MCTP1 
(hMCTP1L and hMCTP1S) were aligned. Asterisks indicate residues which are 
identical among rMCTP1 and hMCTP1 isoforms. Colons indicate that one of the 
following 'strong' groups is fully conserved: STA, NEQK, NHQK, NDEQ, 
QHRK, MILV, MILF, HY, and FYW. Dots indicate that one of the following 
'weaker' groups is fully conserved: CSA, ATV, SAG, STNK, STPA, SGND, 
SNDEQK, NDEQHK, NEQHRK, FVLIM, and HFY. Black dashes represent the 
sequences which do not exist in the gene product. Sequences which were 
highlighted in yellow were C2 domains. Ca2+ binding aspartic acid residues were 
highlighted in red. TMRs were indicated by blue boxes and the antigen which was 
used for Ab generation was indicated by green underline.  
 
Since C2C domain of hMCTP1 is the only C2 domain showing phospholipid 
binding ability (Shin et al., 2005), we analyzed the 3D structure of this domain in 
detail. Predicted 3D structure of MCTP1S C2C domain revealed that this domain 
belongs to the type II C2 domain, in which the N and C termini emerge at the 
bottom of the C2 domain (Fig. 3-3). C2C domain of MCTP1S consists of eight β 
strands and loops on top of the domain. C2 signature residues and N-
myristoylation site are present in the top loops, which indicate the Ca2+ and 





Figure 3-3. Predicted 3D structure of C2C domain of MCTP1S. 
MCTP1 3D structure was predicted by using ESyPred3D software. N and C 
terminal amino acids were shown in red letters. Secondary structure was color 
coded showing the β strands in the left panel. C2 signature regions which are 
critical to bind Ca2+ were shown in red in the middle panel. N-myristoylation site 
which is important for membrane binding was shown in blue in the right panel. 
 
1.1.2 MCTP1 expression in different CNS regions 
Regional expression profile of MCTP1 in adult rat CNS was revealed by both ISH 
and IHC. As shown in Figure 3-4, MCTP1 mRNA is quite widely expressed in 
brain, but the highest expression levels are detected in the following regions: (1) 
limbic system, including piriform cortex, amygdala, subiculum, and hippocampus; 
(2) other brain regions closely involved in emotion information processing, 
including PFC, CPu (striatum), habenula; (3) nucleus related to motor function, 
including supraoptic nucleus, superior colliculum-parabigeminal nucleus, 
trochlear nucleus, facial motor nucleus, and spinal cord ventral horn; (4) granule 





Figure 3-4.  Regional expression profile of Mctp1 mRNA in rat CNS.  
Coronal sections of adult rat CNS are arranged from rostral to caudal levels. 
Higher magnification of the framed regions are shown in a to j. Negative control: 






Immunoperoxidase staining revealed that the regional expression features of 
MCTP1 immunoreactivity are consistent with its mRNA distribution (Fig. 3-5). 
Brain regions of limbic system, habenula, CPu, and supraoptic nucleus showed 
high expression of MCTP1 at both mRNA and protein levels. Some sub-regional 
differences between ISH and immunoperoxidase staining data were noted, and 
might have resulted from the different subcellular localization of the mRNA and 
protein (Fig. 3-5). Interestingly, MCTP1 protein is especially abundant in the 
mossy fiber presynaptic terminals originating from dentate gyrus granule cells 
(Fig. 3-5B). Semi-quantitative analyses of MCTP1 regional distribution in the rat 







Figure 3-5.  Comparison of Mctp1 mRNA and protein expression in selected 
brain regions.  
A, Mctp1 mRNA expression in the limbic system is revealed by ISH. B, MCTP1 





using in-house made anti-MCTP1 Ab. Scale bar in A and B, 500 µm. C-H, Higher 
magnification images showing the high expression of both Mctp1 mRNA (C, E, 
G) and protein (D, F, H) in selected brain regions. MHb: medial habenular 
nucleus; CPu: caudate putamen (striatum); SO: supraoptic nucleus. Scale bar in 
C-H, 200 µm.  
 
Table 3-1. Regional expression of Mctp1 mRNA in the rat CNS.  
Brain regions  MCTP1 expression intensity 
Piriform cortex (pyramidal cells) ***** 
Sensory motor cortex ** 
Other neocortical areas ** 
Striatum ***** 




















Trochlear nucleus ***** 
Cerebellum granule cells ***** 
Pons Pontine nuclei ***** 
Facial motor nucleus ***** 
Spinal 
cord 
Dorsal horn *** 






It is interesting to notice that brain regions with high MCTP1 expression, 
including limbic system, PFC, CPu (striatum) and habenula, are all essential for 
emotional information perception, processing and storage. In these regions, 
MCTP1 is mainly expressed in cells which show neuronal morphology and 
location. To confirm the cell type expressing MCTP1, double IF was carried out 
using the in-house MCTP1 antibody together with various CNS cell type markers.  
As shown in Figure 3-6A-H, MCTP1 showed good colocalization with the 
neuronal maker, NF200, within neuronal cell bodies in various brain regions. By 
contrast, there is no obvious MCTP1 expression in astrocytes (marked by GFAP), 
oligodendrocytes (marked by CNPase) or microglia (marked by OX42 antibody) 
(Fig. 3-6J-L). These results indicate that MCTP1 expression is not uniform but is 
found mainly in neurons in rat brain. 
 
Figure 3-6. MCTP1 is mostly expressed in neurons in adult rat CNS.  
A-H show neuronal expression of MCTP1 in CA3 region of hippocampus (A-D) 
and neocortex (E-H). DAPI staining (blue) is used to visualize cell nucleus. 
MCTP1 (A & E) is mostly expressed in neuronal cells which are labeled by 





in D & H. Scale bar, 20µm. I-L, MCTP1 is rarely expressed in glia cells. 
Confocal images were taken from neocortex (I), hippocampus (J), and cerebellum 
(K & L). MCTP1 is highly expressed in neurons labeled by NF200 (I) but not in 
astrocytes labeled by GFAP (J), oligodendrocytes labeled by CNPase (K), or 
microglia labeled by OX42 (L). Scale bar, 50µm.  
 
1.2.3 MCTP1 expression during CNS development 
Regional expression of MCTP1 in postnatal developing brain was analyzed by 
immunoperoxidase staining at postnatal days (PD) 1, 7, 14 and 28 (Fig. 3-7). At 
PD1, weak MCTP1 expression can be detected in cerebral cortical areas and 
hippocampus formation. In the hippocampus, MCTP1 is mainly expressed in 
projection neurons. In the cerebral cortex, MCTP1 expression can be detected in 
cortical plate (CP) and neuroepithelium (NE) (Fig. 3-8B). It is also noticed that 
primary motor and sensory cortex shows the strongest expression of MCTP1. At 
PD7, MCTP1 expression in brain regions, including CP, hippocampus, thalamus, 
and hypothalamus, becomes much higher as compared with that at PD1. At this 
stage, not only primary motor and sensory cortex, but the entire neocortex shows 
substantial MCTP1 expression. However, the temporal lobe, which is separated 
from other neocortical areas by rhinal fissure, shows no MCTP1 expression. Third, 
MCTP1 staining is concentrated in a juxtanuclear subcellular structure (Fig. 3-
8G). At PD14, MCTP1 expression is mostly restricted to cortex. Different from 
PD7, neurons in temporal lobe began to express MCTP1 at this stage. At the 
subcellular level, MCTP1 is detected in neuronal cell bodies and concentrated at 
the axon initiation site at this stage (Fig. 3-8H). At PD28, MCTP1 expression can 
be found in cortex, hippocampus, thalamus and striatum. Comparing with earlier 
developmental stages, this stage shows two special features of MCTP1 expression. 
First, not all layers, but only layer V neurons, show high expression of MCTP1. 






Figure 3-7. Regional expression profile of MCTP1 in developing rat brain. 
MCTP1 protein expression in developing rat brain was revealed by 
immunoperoxidase staining. PD1, 7, 14 and 28: postnatal days 1, 7, 14 and 28. 









Figure 3-8. Expression of MCTP1 in developing cortex.  
A, Real-time qPCR showed the relative expression level of MCTP1 mRNA in 
cultured developing cortex neurons. Mctp1 mRNA expression levels in DIV4 and 
DIV13 neurons were normalized with that of DIV1 neurons. Values were the 
average from three independent culture batches. MCTP1 mRNA expression in 
DIV13 neurons shows significant increase (P = 0.0017) compared with that of 
DIV1 neurons. MCTP1 mRNA expression shows no significant difference 
between DIV1 and DIV4 neurons. B-E, Higher magnification images of the areas 
which were indicated by black boxes in Figure 3-7. CP, cortical plate; NE, 
neuroepithelium; layer V, layer V of neocortex. Scale bar, 300μm. F-I, Boxed 
areas in B-E were enlarged and shown. Scale bar, 100μm.     
 
In cultured primary neurons, we also found a dramatic increase of MCTP1 mRNA 
in mature neurons (13 days in vitro (DIV13)) compared to young developing 
neurons (DIV1) (Fig. 3-9). In contrast, the expression of MCTP1 in DIV4 
neurons did not show significant difference from that in DIV1 neurons. As 
documented in numerous papers, the initiation of neuronal polarity happened 
within 2d to 4d after seeding, while the peak of synaptogenesis occurs during the 





MCTP1 mRNA didn’t change during the neuronal polarization stage but showed 
a dramatic increase along with synaptogenesis. 
1.2 MCTP1 expression in non-neuronal tissues 
Previous studies have shown MCTP1 expression in multiple tissues besides brain 
(Shin et al., 2005). Using IF staining, we compared cell type and subcellular 
expression of MCTP1 in different tissues, including spleen, fascia (connective 
tissue in muscle) and white blood cells (WBC). MCTP1 expression in neurons in 
facial nucleus was used as a positive control. In spleen, MCTP1 expression can 
only be found in big cells possessing multiple fused nuclei (Fig. 3-9), which 
might be macrophages. Faint IF signal in surrounding lymphocytes was proved to 
be nonspecific, since it is also found when no primary Ab was applied. 
Subcellularly, MCTP1 is concentrated in vesicular or membranous structures 
lying around the nucleus in these MCTP1 positive cells (Fig. 3-9). In fascia, 
MCTP1 expression can be clearly detected in fibroblast cells (Fig. 3-9). 
Subcellularly, MCTP1 is localized on a compact, perinuclear structure in 
fibroblast cells in fascia (Fig. 3-9). In WBC, MCTP1 is highly expressed in 
granulocytes, including neutrophils, basophils and eosinophils. By contrast, 
MCTP1 expression in lymphocytes and monocytes is much lower (Fig. 3-9). 
Subcellularly, MCTP1 is localized on dispersed distributed granules in blood 








Figure 3-9. Expression and subcellular localization of MCTP1 in multiple 
tissues.  
Confocal images showing  expression and subcellular localization of MCTP1 
(green) in neurons of facial nucleus, some cells in spleen, blood granulocytes, and 
fibroblasts in fascia. DAPI staining (blue) reveals the cell nucleus. Scale bar, 20 
µm 
 
2. Subcellular localization of MCTP1 in neuronal cells 





In the stratum lucidum of the hippocampus, positive immunostaining of MCTP1 
colocalized with Syp, indicating MCTP1 distribution in the mossy fiber 
presynaptic terminals originating from dentate gyrus granule cells (Fig. 3-10A-C). 
The subcellular localization of MCTP1 on presynaptic terminals was further 
verified in cultured primary neurons. In DIV13 neurons, MCTP1 staining is well 
colocalized with Syp (Fig. 3-10D-F).   
Immunoelectron microscopy (IEM) revealed MCTP1 on the membrane of SV 
(Fig. 3-10G-L). Representative synapses found in mossy fiber terminal of granule 
cells in hippocampus and molecular layer of Cerebellar cortex were shown in 
Figure 3-10G-L. Selected regions were defined as synapses based on the 
observation of presynaptic terminals containing SVs (indicated by green arrows in 
Fig. 3-10G-L) and postsynaptic membrane thickening (indicated by red arrows in 
Fig. 3-10G-L).  In CA3 stratum lucidum, MCTP1-positive synaptic Vesicles have 
the following features: (1) the presynaptic bags containing these vesicles are large 
and with irregular outlines, which indicate mossy fiber endings, (2) the vesicles 
appear spherical and clear (indicative of excitatory vesicles), and (3) sizes of the 
vesicles are relatively small (about 40 nm in diameter). Neither oval appearance 
vesicles nor larger vesicles were observed immunoreactive for MCTP1. In the 
molecular layer of cerebellum, the appearance of the vesicles with MCTP1 
staining is similar to the ones in hippocampus. These findings implied a 







Figure 3-10. MCTP1 is concentrated on presynaptic terminals in mature 
neurons.  
A-F, Double IF images showing the concentration of MCTP1 (green) in 
presynaptic terminals labeled by Syp (red). A-C show mossy fiber terminals in 
CA3 region of adult rat hippocampus. D-F show cultured DIV13 cortical neurons. 
DAPI (blue) reveals cell nucleus. Boxed areas were enlarged and shown as inset 
on the upright corner. Scale bar, 20 µm. G-L, IEM graphs show MCTP1 on the 
membrane of small, round, and clear synaptic vesicles (SV) in hippocampal CA3 





cerebellar cortex (J-L). Red arrowheads point to post synaptic density and green 
arrows to SV. Scale bar, 0.2 µm. 
 
2.2 MCTP1 targets intracellular vesicles via its TMR 
The above finding of MCTP1 on SV prompted us to further investigate the 
involvement of MCTP1 in the intracellular vesicle trafficking. To this end, we 
carried out in vitro imaging study utilizing PC12 cells, which is widely used in 
neuronal vesicular trafficking studies. Our in vitro imaging study focused on 
MCTP1S, the major MCTP1 isoform in the adult brain (Fig. 3-4). Under confocal 
live imaging, the steady state subcellular localization of overexpressed mCherry-
MCTP1S was vesicular (Fig. 3-11A), in contrast to mCherry-MCTP1T which 
showed a diffuse distribution in transfected cells (Fig. 3-11B), indicating that the 
membrane localization of MCTP1 depends on the TMRs. Time-lapse confocal 
live imaging revealed two populations of MCTP1S-positive vesicles according to 
their location and moving speed (Fig. 3-11A & C). One population found in the 
central part of the cells showed bigger sizes and infrequent movement (0.08017 ± 
0.01672 µm/sec, n = 64) (Fig. 3-11A, arrow head), the other type located in the 
periphery of host cells has smaller sizes and high mobility (0.2206 ± 0.05794 
µm/sec, n = 46, P = 0.0091) (Fig. 3-11A, arrow). One tubular structure which is 
moving rapidly from central part of the cell to the peripheral region of the cell 
was shown in Figure 3-11D as an example of the second population of MCTP1S 






Figure 3-11. Vesicular targeting of MCTP1 is mediated by its TMRs.  
A-B, Confocal images show vesicular localization of mCherry-MCTP1S but 
diffused expression of mCherry-MCTP1T. Scale bar, 10 µm. C, MCTP1S 
positive vesicles show distinct mobile features. Vesicles localized centrally, 
which are indicated by arrowhead in A, seldom move. Vesicles localized 
peripherally, which are indicated by arrow in A, are highly mobile. Scatter dot 
plot shows the moving speed of these two populations of MCTP1 expressing 
vesicles. **P<0.01 D, Time-lapse confocal live images show the rapid, outward 
movement of the tubular structure which is indicated by red arrow in A. Scale bar, 
2 µm.   
 





PC12 cells possess mainly two types of secretory vesicles:  LDCV which contains 
catecholamine (including DA, norepinephrine, etc) and SLMV which contains 
acetylcholine (Greene & Rein, 1977). NPY is commonly used as a LDCV marker, 
while VAChT labels SLMV and recycled SLMV membrane. Vamp2, which is 
enriched in SVs in neurons, can be present on both LDCV and SLMV, and also 
can be found on Golgi and endosome in PC12 cells. MCTP1S expression product 
rarely appeared on NPY-positive LDCVs localized either centrally or beneath the 
PM (Fig. 3-12C), but showed substantial colocalization with VAChT (Fig. 3-12F) 
and Vamp2 (Fig. 3-12I). However, it is also noticed that the MCTP1S was not 
found on the VAChT positive structures which had irregular shape and positioned 
beneath the PM (Fig. 3-13). Thus, MCTP1S was present on selected cellular 






Figure 3-12. Localization of MCTP1S on selected cellular vesicles in PC12 
cells.  
Confocal images of representative PC12 cells show distribution of MCTP1S (A, 
D and G) co-transfected together with various secretory vesicle markers (B, E and 
H). Framed areas were enlarged and shown as insets. MCTP1S showed minimal 
colocalization with NPY (C) which labels LDCVs, but substantial colocalization 
with VAChT (F) on SLMVs or recycled SLMV membrane. However, the 
colocalization did not happen in the cell center. MCTP1S also showed partial 
colocalization with Vamp2 (I) which labels all secretory vesicles. Scale bar, 10 
µm.  
 
Figure 3-13. Absence of MCTP1S on a subset of VAChT positive structures 
beneath PM.  
Confocal images show the absence of MCTP1S (A and D) on a subset of VAChT 
(B and E) positive structures which lie just beneath the PM and show irregular 
morphology (indicated by white arrows). Boxed area in upper panel was enlarged 
and shown in the lower panel. Scale bar, 10 µm.   
 
2.4 localization of MCTP1 at compartments of the endocytic recycling 
pathway 
In immature primary neurons (DIV4 neurons) and undifferentiated PC12 cells, 
MCTP1 immunostaining was detectable but quite low. In these cells, MCTP1 was 
concentrated on perinuclear RE marked by TfR (Fig. 3-14, A, E, I & B, F, J). 





primary neurons (Fig. 3-14, C, G, K), although weaker signal of overexpressed 
MCTP1S was also detectable in neuronal processes. However, the subcellular 
localization of MCTP1 appeared more widely distributed in mature neurons (Fig. 
3-14, D, H, L), which means the subcellular location of MCTP1 is subjected to 
change during neuronal maturation.    
Figure 3-14. MCTP1 is concentrated on perinuclear RE in immature neurons 
and PC12 cells, but more widely distributed in mature neurons.  
Double IF images show colocalization of endogenous MCTP1 (E, F, H) with RE 
marker TfR (A, B, C, D) in both PC12 cells (A, E, I) and DIV4 cortical neurons 
(B, C, F, G, J, K). Transfected MCTP1S (G) is also colocalized with TfR in DIV4 
cortical neurons (K). In contrast, endogenous MCTP1 show more dispersal 
distribution in DIV21 neurons (D, H, L). DAPI (blue) reveals cell nucleus. Scale 
bar, 10 µm. 
In PC12 cells, overexpressed MCTP1S showed significant colocalization with 
Rab5a (marker of early endosomes) and Rab11a (marker of slow RE), but not 
with peroxisome marker (negative control) (Fig. 3-15). Quantification showed a 
Pearson’s coefficient of -0.05875 ± 0.03913 (not significant correlation) for 
MCTP1S colocalization with peroxisome, of 0.566 ± 0.05889 (significant 





correlation) for colocalization with Rab11a (Fig. 3-15D, H and L). In comparison 
with Rab11a, The higher correlation between MCTP1S and Rab5a probably 
reflected the high Rab5a expression on MCTP1S positive vesicles. Rab11a 
showed only moderate expression on MCTP1S positive vesicles. However, the 
difference is not statistically significant between Rab5a and Rab11a correlations 
with MCTP1S. The partial colocalization of MCTP1S with Rab11a and Rab5a 
suggested MCTP1 involvement only in part of the endocytic recycling pathway. 
 
Figure 3-15. Subcellular localization of MCTP1S on endocytic recycling 
pathway.  
Confocal images of representative cells show significant colocalization of 
MCTP1S (A, E and I) with endocytic recycling pathway markers Rab5 (F) and 
Rab11 (J), but not with peroxisome marker (B) that served as a negative control. 
Boxed areas were enlarged and shown as insets in the lower-left corner. Scale bar, 
10 µm. Quantification of the colocalization between MCTP1S and endocytic 
recycling pathway markers is shown in D, H and L, respectively.  
 





3.1 MCTP1S overexpression reduced the endocytosis of recyclable cargoes. 
To decipher whether MCTP1S overexpression would influence endocytic 
recycling process, we compared the internalization and trafficking of Tf488 
between mCherry-MCTP1S overexpressing and mCherry overexpressing PC12 
cells (serving as control cells). The temporal and spatial trafficking of Tf488 in 
mCherry-MCTP1S overexpressing cells showed a dynamic profile similar to that 
of control cells (Fig. 3-16A). In the initial stage, pits of Tf488 signal in both 
mCherrry-MCTP1S overexpressing cells and control cells appeared evenly 
distributed (Fig. 3-16A, 0min). Around 10 min later, Tf488 signal in both 
mCherrry-MCTP1S overexpressing cells and control cells appeared centralized 
and compact (Fig. 3-16A, 10 min) and then faded out by 60 min (Fig. 3-16A, 60 
min) as all Tf488 had been recycled out from the cells. As compared with control 
cells, however, MCTP1S overexpressing cells showed lower Tf488 fluorescence 
intensity at the 0min time point (Fig. 3-16A, 0min, indicated by white arrow). 
This finding was further investigated and confirmed by quantification using flow 
cytometry (Fig. 3-16B). At 0min time point, 75.98 ± 1.175 % of control mCherry 
transfected cells showed Tf488 fluorescence intensity above threshold (set 
according to cells with no Tf488 labeling), similar to that of untransfected cells in 
the same sample (72.09 ± 1.933%) and also similar to untransfected cells in the 
mCherry-MCTP1S transfected sample (75.23 ± 1.184%). In contrast, only 55.53 
± 1.295% of mCherry-MCTP1S transfected cells showed Tf488 binding 
fluorescence signal above threshold (Fig. 3-16Ba). Average Tf488 fluorescent 
intensity of mCherry-MCTP1S transfected cells (112.6 ± 2.804, n = 5) was also 
consistently and significantly lower than that of the control mCherry transfected 
cells (144.3 ± 1.315, n = 4) (P < 0.0001) at 0min time point (Fig. 3-16Bb). This 
difference persisted at all of the subsequent time points except the last one (Fig. 
3-16Bc). Average fluorescence intensity of Tf488 in mCherry-MCTP1S 
transfected cells was 72.75 ± 3.326 at 10min and  51.75 ± 1.493 at 30min, which 
were significantly lower than those of the mCherry transfected cells [91.75 ± 
3.326 at 10min (n = 4, P = 0.0068) and 60.75 ± 2.358 at 30min (n = 4, P = 0.018)]. 





endocytosis of the recyclable membrane materials, but had no obvious effect on 
subsequent recycling process.  
 
Figure 3-16. MCTP1S overexpression reduced endocytosis of Tf488.  
A, Internalization and recycling of Tf488 in mCherry-MCTP1S transfected and 
mCherry transfected PC12 cells were revealed by confocal imaging. Upper panels 
show Tf488 signals within cells at various time points following washout of 
unbound Tf488. Corresponding mCherry signal of the same fields were shown in 
the lower panels to indicate the transfected cells (white arrows in the upper 
panels). The signal of internalized Tf488 in mCherry-MCTP1S transfected cell is 
obviously lower than neighboring non-transfected cells at 0min time point. Scale 
bar, 20 µm. B, Cells identically treated as in A were collected at various time 
points and subjected to flow cytometry analyses. a, Comparison of number of the 
cells which show higher fluorescence than threshold at 0min time point. mCherry-
MCTP1S transfected group shows significantly fewer cells with Tf488 binding 
fluorescence above threshold than the other three groups. n = 3, ****P < 0.0001 
versus mCherry transfected cells. b, Comparison of the mean fluorescence 
intensity between mCherry-MCTP1S transfected cells and mCherry transfected 
cells at 0min time point. n = 3, ***P<0.001. c, Mean fluorescence intensity of 
Tf488 was compared between mCherry-MCTP1S transfected cells and mCherry 
transfected cells at various time points to reveal the dynamic recycling of Tf.       
 
3.2 MCTP1S overexpression retarded secretory vesicle retrieval 
Possible involvement of MCTP1 in secretory vesicle retrieval was also studied in 





vesicles using real-time TIRFM imaging. PHluorin is a pH sensitive GFP (Ashby 
et al., 2004). The fluorescence of this protein is very weak in an environment of 
pH <6.0 but dramatically increases in an environment of pH >7.0. When Vamp2-
pHluorin-labeled secretory vesicles undergo exocytosis, the environmental pH of 
pHluorin will increase from 5.5 to 7.4. Thus the exocytosis event is accompanied 
by a burst of a bright dot under TIRF microscope, while other Vamp2-pHluorin 
labeled intracellular vesicles remained much fainter (Burchfield et al., 2010). 
Under TIRFM imaging, mCherry-MCTP1S was observed on Vamp2-pHluorin 
positive vesicles which are undergoing exocytosis (Fig. 3-17A-F). For most of the 
events recorded in our study, the pHluorin fluorescence of exocytosis events 
increased abruptly (within 50 ms) and decreased gradually (within 3s for the 
exampled case in Fig. 3-17H). Under normal condition (2.2 mM CaCl2, 5.6 mM 
KCl), no obvious difference was detected in fusion rate of Vamp2-pHluorin-
bearing vesicles to the PM between MCTP1S overexpressing cells (28.38 ± 8.15, 
n = 8) and control cells (24.2 ± 10.63, n = 10) (P = 0.4) (Fig. 3-17G).  
We next analyzed the retrieval kinetics of single exocytosis event by measuring 
pHluorin fluorescence decay time (τ) (time required for a vesicle retrieval event to 
bring about 63.2% decay of the exocytosis-elicited fluorescence from peak 
intensity as illustrated in the lower panel of Fig. 3-17H). Frequency distribution 
histogram of decay time for all recorded exocytosis events was illustrated in 
Figure. 3-17I & J. The peak of the histogram shifted toward the right (longer 
decay time) in MCTP1S overexpressing cells (Fig. 3-17J). In control cells, 22.48% 
of the total events (n = 436, 15 cells) had a decay time less than 0.5s. By contrast, 
in MCTP1S overexpression cells, only 13.23% of the total events (n = 597, 15 
cells) had a decay time less than 0.5s. This indicated that MCTP1S 






Figure 3-17. MCTP1S overexpression retarded secretory vesicle retrieval. 
Secretory vesicle exocytosis and retrieval were monitored by fluorescence change 
of Vamp2-pHluorin using live TIRF imaging. Example TIRFM images show the 
presence (C & F) of MCTP1S (A & D) on secretory vesicles undergoing 
exocytosis (B & E). A, B and C show the original TIRFM images of a mCherry-
MCTP1S and Vamp2-pHluorin double transfected PC12 cell. D, E and F show 
the images generated by Imaris to display only the signal positive vesicles. Red 
particles represent MCTP1S expressing vesicles. Green particles are the ones 
undergoing exocytosis and hence showing much higher fluorescence of Vamp2-
pHluorin. Scale bar, 10 µm. G, Comparison of the fusion rate between MCTP1S 
overexpressing cells and control cells (empty vector transfected cells). Fusion rate 
was defined as new exocytosis events within 1 min on each cell. H, An example 
shows how secretory vesicle retrieval is measured. In the upper panel, serial 





they are taken. The time point when the fluorescence of the event reaches the 
peak is referred as 0 second. Fluorescence of the exocytosis event shown in the 
upper panel was plotted as a function of time in the lower panel. In the lower 
panel, Vamp2-pHluorin fluorescence decay time, as indicated by the length of the 
red line, refers to the time (in seconds) taken for the fluorescence to decline back 
to 36.8% of the peak above F0. F0: local background fluorescence intensity; ΔF: 
peak fluorescence intensity of recorded exocytosis event minus F0; Ft: 
fluorescence intensity of the decay time point. Scale bar, 1 µm. I & J, Frequency 
distribution of the decay time of the exocytosis events are plotted as histograms. 
The peak of the histogram shifted toward the right (longer decay time) in 
MCTP1S overexpressing cells.  
We also conducted Ab uptake experiment to detect the PM bond Vamp2-pHluorin. 
Vamp2-pHluorin was co-transfected with either MCTP1S-HA or HA empty 
vector (serving as control) into PC12 cells. The efficiency of co-transfection was 
around 90% as shown in Fig. 3-18A & B. Ratio of the two co-transfected 
plasmids was adjusted to ensure that the expression of Vamp2 is equal between 
the experimental and control groups (Fig. 3-18C). Confocal images of the bottom 
plane of the transfected cells were taken for quantifying the amount of PM bond 
Vamp2. Definition of the PM area (shown by white box in Fig. 3-18D & E) was 
illustrated in Material and Method section. PM bound GFP Ab was visualized by 
red fluorescence (Alexa Fluor 568 IgG) (Fig. 3-18D & E). As shown in Figure 3-
18D-F, MCTP1S-HA transfected cells have more PM bound Vamp2-pHluorin 
(46.46 ± 3.928, n =18) compared with that in control cells (37.02 ± 2.715 n =22) 







Figure 3-18. MCTP1S overexpression increases the membrane incorporation 
of Vamp2-pHluorin.  
A & B, Co-transfection is confirmed by immunocytochemistry. Vamp2-pHluorin 
(A) and HA-MCTP1S (B) were co-transfected into PC12 cells. Cells which show 
positive expression of Vamp2-pHluorin (green cells in A) also show a positive 
staining of HA (red cells in B). Scale bar, 50 µm. C, western blot shows equal 
total expression of Vamp2-pHluorin (anti-GFP) in these two groups of cells. D & 
E, Representative cells show uptaken and PM bound Vamp2-pHluorin (indicated 
by white boxes). Scale bar, 10 µm. F, Bar charts show the statistic comparison of 
PM incorporated Vamp2-pHluorin between MCTP1S overexpressing cells and 
control cells. Data shown is mean fluorescence intensity.  
 
3.3 MCTP1S overexpression had no effect on Glutamate release from 
SHSY5Y cells 
We next examined whether MCTP1S overexpression can affect the glutamate 
release from SHSY5Y cells which is a human neuroblastoma cell line. To achieve 
this, we first generated a mCherry-MCTP1S stable overexpression SHSY5Y cell 
line. In mCherry-MCTP1S stable overexpression cells, The subcellular 
localization of both mCherry and MCTP1S, which is perinuclear, is the same as 
endogenously expressed MCTP1 in PC12 cells (Fig. 3-19A-C). This indicated 





likely to be similar to the endogenous MCTP1. Under normal condition (2.2 mM 
CaCl2, 5.6 mM KCl), MCTP1S overexpressing cells showed a slightly more 
glutamate release (1.139 ± 0.06, n = 14) compared to control SHSY5Y cells (Fig. 
3-19D). However, there is no statistically significant difference between these two 
groups. When subjected to high K+ extra cellular solution (ECS), 115 mM KCl 
can reliably induce a significant increase of glutamate release from both control 
SHSY5Y cells (1.541 ± 0.06440 fold increase, P < 0.0001, n =14) and MCTP1S 
overexpressing SHSY5Y cells (1.706 ± 0.1773 fold increase, P = 0.0016, n = 14) 
in comparison to the glutamate release from cells under normal ECS (Fig. 3-19D). 
However, paired t test showed no significant difference in the glutamate release 
between MCTP1S overexpressing cells and control cells under high K+ conditions. 
These findings indicate that overexpression of MCTP1S has no significant effect 
on the glutamate release in SHSY5Y cells either under normal condition or under 






Figure 3-19. MCTP1S overexpression has no effect on glutamate release in 
SHSY5Y cells.  
The perinuclear localization of MCTP1 (A) and mCherry (B) in mCherry-
MCTP1S overexpressing SHSY5Y cell line is the same as the subcellular 
localization of endogenous MCTP1 in PC12 cells. Scale bar, 10 μm. D, Bar chart 
shows the relative glutamate release from control SHSY5Y cells (SHSY5Y) and 
MCTP1S overexpressing SHSY5Y cells (MCTP1S-OE) under either normal 
condition (ECS) or high K+ stimulation (H K+). Data were normalized to the 
glutamate release from control SHSY5Y cells under normal condition and 
presented as fold change.     
 
3.4 MCTP1L overexpression retard neuronal cell migration 
Cell migration is closely related to RE trafficking (Kartikasari et al., 2009; 
Kawauchi et al., 2010). We examined the effect of MCTP1 on neuronal cell 
migration by wound healing scratch assay. SHSY5Y cells were used because they 
can form a nice monolayer and show good migration behavior. Since the 
transfection efficiency of MCTP1S was low in SHSY5Y cells and MCTP1L also 
show RE localization (Fig. 3-20), we overexpressed HA-MCTP1L in this assay. 
JN141, which was a truncated inactive form of Juxtanodin (JN) (Zhang et al., 
2005; Li et al., 2007; Meng et al., 2010), was used as a control. There is no 
significant difference between the percentage of the MCTP1L overexpressing 
cells (14.28 ± 0.56%) and JN141 overexpressing cells (14.68 ± 1%) among total 
cells in the non-migrated zones (P = 0.7294), which indicated that the transfection 
efficiencies of these two plasmids were more or less the same (Fig. 3-21). In 
contrast, the percentage of MCTP1L overexpressing cells (10.13 ± 1.54%) is 
significantly lower than the percentage of JN141 overexpressing cells (19.01 ± 
2.52%) among cells in the migrated region of the scratch wound (P = 0.011) (Fig. 
3-21). The percentage of JN141 overexpressing cells showed no significant 
difference between the migrated and non-migrated regions (P = 0.0637). However, 
the percentage of MCTP1L overexpressing cells in migrated wound region was 
significantly lower than that in non-migrated region (P = 0.0040). This result 
suggested that overexpression of MCTP1L retarded the migration of host 






Figure 3-20. MCTP1L also localized on perinuclear RE compartment.  
MCTP1L-HA (green) was transfected into SHSY5Y cells. Perinuclear RE 
compartment is labeled by TfR (red). The colocalization between MCTP1L and 
TfR appears yellowish in the merged picture. Scale bar, 10 μm. 
 
Figure 3-21. MCTP1L overexpression retarded neuronal cell migration as 
evaluated by scratch assay.  
JN141 transfection served as a control. JN141 transfected cells (A) were mixed 
together with MCTP1L transfected cells (B) and seeded in the same well. White 
line indicated the scratch border captured immediately after scratching. DAPI 
stains all cell nuclei (C). Cells lying between the two borders (white lines) are the 
migrated cells. Scale bar, 200 µm. D, Statistical comparison of the migration rate 
of the transfected cells was presented as bar chart. The migration rate was 
revealed by the relative number (% of total cell number (DAPI staining)) of the 
migrated cells. The number of non-migrated MCTP1L overexpressing cells shows 





migrated MCTP1L overexpressing cells was significantly lower than that of 
control group. *P < 0.05 versus control.      
3.5 MCTP1 overexpression protect PC12 cells from oxidative insult 
Oxidative insult may cause neuronal cell death and contribute to pathogenesis of 
many neurological diseases. Since MCTP1 has been implicated in various 
neuropsychiatric diseases and is involved in RE trafficking, we tested whether 
MCTP1 also affects cell’s response to oxidative insult. Intriguingly, both 
MCTP1S and MCTP1L overexpression decreased the intracellular ROS level of 
PC12 cells as compared with JN141 transfection (Fig. 3-22A). When normalized 
to the ROS level in JN141 transfected cells, MCTP1L transfected cells showed 
84.08 ± 1.375% (n = 3, P = 0.0003), and MCTP1S transfected cells showed 93.53 
± 2.076% (n = 3, P = 0.0356) ROS level of that in JN141 transfected cells. When 
transfected cells were exposed to 10mM glutamate for 24hrs, ROS level of JN141 
transfected cells increased significantly as indicated by an obvious right shift of 
the histogram of H2DCFDA fluorescence, whereas average ROS level in 
MCTP1S transfected cells did not increase significantly (Fig. 3-22B). After cells 
were exposed to 10mM glutamate for 24hrs, MCTP1L- and MCTP1S-transfected 
cells showed 70.07±6.25% (n = 3, P = 0.0087) and 60.19 ± 5.413% (n = 3, P = 
0.0018), respectively, of ROS level of glutamate-treated JN141 transfected cells 
(Fig. 3-22C & D). These results clearly indicated that overexpression of MCTP1 






Figure 3-22. MCTP1 overexpression protected PC12 cells from oxidative 
insult and glutamate toxicity.  
JN141 transfection served as a control. ROS level was evaluated by measuring 
H2DCFDA fluorescence using flow cytometry. A, MCTP1L and MCTP1S 
transfected PC12 cells show moderately decreased ROS level compared with 
control. *P < 0.05, ***P < 0.001 versus control. n = 3 (n value represented the 
number of independent experimental preparations. More than 10000 cells were 
analyzed for each sample). B, Effects of glutamate treatment on ROS level in 
transfected cells. The ROS level histogram of 10mM glutamate treated JN141 
transfected cells showed an obvious right shift compared with that of non-treated 
JN141 transfected cells. However, The ROS level histogram of 10mM glutamate 
treated MCTP1S transfected cells does not show an obvious right shift compared 
with that of non-treated MCTP1S transfected cells. C, MCTP1 overexpression 
prevented increases of ROS level in 10mM glutamate treated PC12 cells 
compared with control. After 24hrs incubation with 10mM glutamate, MCTP1L 
and MCTP1S transfected cells show an obvious left shifted ROS level histogram 
compared with control. D, MCTP1L and MCTP1S transfected PC12 cells show 
decreased ROS level compared with control in response to glutamate treatment. 



























Taken together, the current study revealed the expression and multiple functions 
of MCTP1 in the nervous system. It was found that MCTP1 was abundantly 
expressed in neurons of brain regions which are involved in emotion information 
processing, like PFC, striatum, habenula, and limbic system and MCTP1 
expression increased dramatically during synaptogenesis. At subcellular level, 
MCTP1 concentrated on SV in mature neurons and had partial but substantial 
colocaliztion with both VAChT and Vamp2 but not with the LDCV marker NPY 
in PC12 cells, which indicated MCTP1 was mostly involved in the activities of 
SLMV and SVs, but not LDCV. MCTP1 also localized on endocytic recycling 
pathway in immature neurons and undifferentiated neuronal cells. Functionally, 
MCTP1 was involved in regulation of such neuronal cell activities as secretory 
vesicle retrieval, cell migration, and oxidative stress.  
1. MCTP1 CNS expression, SNP, splice variation and possible association 
with neuropsychiatric diseases 
Although independent genetic screening studies have suggested association of 
MCTPs with various neuropsychiatric diseases, no previous studies have shown 
the expression features of MCTPs in the mammalian brain. Findings of the 
current study clearly demonstrated a substantial expression of MCTP1 in brain 
regions which are involved in emotion information processing. These findings 
provide a structural basis for the involvement of MCTP1 in the pathology of 
neuropsychological diseases.   
Consistent with previous report (Shin et al., 2005), our current study also revealed 
that MCTP1 isoforms are highly conserved between human and rat, indicating an 
important functional role of MCTP1 in mammals. In addition, the gene structure 
and exon organization of MCTP1 gives us a hint of the association between 
MCTP1 and BD. SNP rs17418283 of MCTP1, which is found associated with BD 
(Scott et al., 2009), is located in the intron before exon 18 which encode the first 
TMR of MCTP1. Analysis of human and rat expressed sequence tags (EST) 





both the species. The TMRs may be critical for MCTP1 functions as they prove 
competent to direct vesicular localization of MCTP1S (Shin et al., 2005). The 
distinct subcellular localization of MCTP1S from MCTP1T, as revealed by the 
present study (Fig. 3-13), further indicated the necessity of the TMRs in targeting 
MCTP1 to vesicular structures. Thus, it would be interesting to see whether and 
how SNP rs17418283 of MCTP1 will affect the splicing of the first TMR or 
expression level of MCTP1.   
The expression of MCTP1 is highly cell type specific. A previous study reported 
MCTP1 expression only in sweet and bitter sensing cells, but not in sour and salt 
sensing cells in taste buds (Moyer et al., 2009). Current study in the rat CNS 
detected expression of MCTP1 mRNA and protein predominantly in neurons, 
especially those of the limbic system, but not much in glial cells. Moreover, in 
peripheral blood, MCTP1 was only observed in granulocytes (neutrophil, 
eosinophil, and basophil) but not in monocytes and lymphocytes. These findings 
indicated that functions of MCTP1 are rather diverse but specific to the various 
cell types, and that the possible MCTP1-involved pathology of 
neuropsychological diseases is more neuron specific. Furthermore, our results 
show that expression of MCTP1 in CNS is region specific. Brain regions, 
including PFC, striatum, habenula, hippocampus, and amygdala, show 
significantly higher expression of MCTP1 compared with other brain regions (Fig. 
3-6). Since these regions are the ones highly involved in mood regulation and 
neuropsychological diseases (Strakowski et al., 1999; Davidson et al., 2000; 
Rajkowska et al., 2001), the high expression of MCTP1 in these regions also 
implies an involvement of this gene in the pathology of neuropsychological 
diseases. It is also noticed that MCTP1 is especially highly expressed in some 
motor neuron clusters in CNS, which may indicate that MCTP1 is more involved 
in the motor aspect of neuropsychological diseases. However, the 
neurotransmitters utilized by MCTP1 expressing neurons tend to be 





The association between Mctp genes and psychiatric disease can be studied more 
directly if Mctp transgenic mouse model is available. Animal models are useful 
tools to study the biological mechanism of neurological diseases. They are 
indispensable to study the developmental, systematical and cyto-architectural 
abnormalities of psychiatric diseases. The discoveries and conclusion gotten from 
the experiments done in vivo is also more reliable and relevant giving that the 
animal provide a complex but real biological context. However, animal modeling 
of psychiatric diseases faces several challenges which may hinder the utilization 
of animals in psychiatric researches. One challenge is the lack of neurobiological 
markers in psychiatric diseases. Unlike AD in which abnormal Aβ aggregation 
and increased phosphorylated tau can serve as biological marker, psychiatric 
diseases don’t have a significant and reliable biological marker, like abnormal 
expression of certain molecules, synaptic dysfunction, or abnormal neuronal 
circuits (Hyman, 2010). Another major challenge is that the symptoms of 
psychiatric diseases are uniquely human. Many symptoms of psychiatric disease 
are quite subjective and the behavior readout is hard to reproduce in animals 
(Hyman, 2010). Some mouse behavior criteria are accepted as relevant with 
human psychiatric diseases. These criteria include hyperactivity, deficient 
working memory, reduced sociability, and reduced prepulse inhibition (PPI) 
(Jamain et al., 2008; Moy & Nadler, 2008; Swerdlow et al., 2008; Chadman et al., 
2009). Impaired PPI is thought to reveal the deficit in sensorimotor gating which 
is involved in psychiatric diseases (Swerdlow et al., 2008). A number of 
transgenic mouse lines are generated to model psychiatric diseases based on the 
discovery of the susceptibility genes associated with psychiatric diseases. For 
example, transgenic mice carrying a truncated DISC1 protein were generated to 
modeling schizophrenia disease. Mice carrying truncated DISC1 were reported to 
show hyperactivity, deficient working memory, and also altered synaptic 
plasticity (Pletnikov et al., 2008). Thus, it seems the animal model can still 
recapture some of the disease features. Animal model of bipolar disorder is still 
not available. Whether a transgenic mouse carrying a null MCTP1 can serve as a 





confirming whether this gene is pertinent in bipolar disorder or not. Nevertheless, 
an animal model carrying a null functioning MCTP1 or MCTP1 knockout mouse 
can certainly advance the functional study on this protein and its associated 
cellular processes. 
2. MCTP1 expression during development implies its involvement in 
synaptogenesis 
Our results also showed a close relation between the expression of MCTP1 and 
the process of neuronal connection establishment. Since neurogenesis and 
neuronal migration are largely prenatal events, at PD1, most neurons of the brain 
are already there. One of the most prominent developmental process happened in 
postnatal brain is synaptogenesis. At PD1, the synaptogenesis in brainstem and 
midbrain are already well developed but the synapses in higher brain regions, like 
cerebral cortex and limbic system, are still very few (Perry, 2000). Our results 
show that MCTP1 expression is quite low in PD1 rat brain compared with later 
developmental stages. Furthermore, MCTP1 expression underwent a regional 
progression during postnatal brain development. It is observed in our study that 
MCTP1 expression first appeared in primary motor and sensory cortex, and then 
in other regions of neocortex, and finally reaches the temporal lobe which is 
involved in emotion and memory. This regional order of MCTP1 expression is the 
same as the regional order of synaptogenesis progression in cerebral cortex. 
Synaptogenesis progress gradually from lower functional regions to higher 
functional regions within cerebral cortex. Primary motor and sensory areas are the 
first regions undergoing synaptogenesis, and other regions governing emotion and 
thought will take the synaptogenesis process later. These findings indicate that 
MCTP1 expression is especially high in the brain regions undergoing 
synaptogenesis. Our in vitro cell culture model also proved that the expression of 
MCTP1 increased dramatically at DIV13, a time when in vitro neurons are in the 
peak of synaptogenesis (Corvin et al., 2007).  





Many proteins with multiple C2 domains and TMR localize on the membrane of 
trafficking vesicles. For example, Syt I, V, and IX are present on dense-core 
vesicles (Xu et al., 2007); Syt VII localized on lysosome (Martinez et al., 2000; 
Jaiswal et al., 2004; Rao et al., 2004); while myoferlin were found in the 
endocytic recycling pathways (Doherty et al., 2008; Bernatchez et al., 2009). The 
prominent C2 domains and TMRs of MCTP1 (Fig. 3-1) lead to the speculation 
that MCTP1 is also localized on transporting membranes. Indeed, MCTP1 is 
localized on intracellular vesicular structures both in vivo and in vitro. Co-
labeling with various vesicular structure markers revealed that MCTP1 targets to 
both secretory pathway and endocytic recycling pathway.  
In secretory pathway, endogenous MCTP1 colocalized well with Syp and is 
highly concentrated on the SV membrane in mature neurons (Fig. 3-10). 
Overexpressed MCTP1S also showed colocalization with Vamp2 and VAChT, 
but no colocalization with LDCV marker NPY in PC12 cells (Fig. 3-12). This 
indicated that MCTP1 was not much related with LDCV, which is an analogue of 
secretory granules in endocrine cells and generated from regulated secretory 
pathway (Bauerfeind and Huttner, 1993; Hannah et al., 1999). On the other hand, 
MCTP1 appears to be more related with SVs and SLMVs which are generated 
from recycling pathway (Ceccarelli et al., 1973; Heuser and Reese, 1973; Sudhof, 
1995; Cremona and De Camilli, 1997). Consistently, MCTP1 was found to be 
localized on both early endosome and RE in PC12 cells (Fig. 3-14, 3-15). Thus, it 
is possible that, like Syp, newly synthesized MCTP1 is transported to plasma 
membrane via constitutive secretory pathway and then arrived at SVs through 
endocytic recycling (Regnier-Vigouroux et al., 1991).  
The localization of MCTP1 in endocytic recycling pathway is very similar to that 
of Ferlins (Evesson et al., 2010), another group of multiple C2 domain proteins 
which are also anchored to membrane by C terminal TMR (Davis et al., 2002). 
Ferlins are found to be important mediators in endocytic recycling pathway 
(Jimenez and Bashir, 2007) and their loss of function has been reported to cause 





muscles, heart and brain. These similarities imply that MCTP1 may exert similar 
functions as Ferlins. 
4. Role of MCTP1 in endocytic recycling  
In mammalian cells, most membrane trafficking and fusion process requires Ca2+.  
Many proteins with multiple C2 domains and TMR are key molecules to mediate 
membrane trafficking and fusion (Sudhof, 2002; Bansal & Campbell, 2004). The 
structural features of MCTP1 and its localization on SV and endocytic recycling 
pathway raised the possibility that MCTP1 might be involved in secretory vesicle 
trafficking and fusion. In the present study, overexpression of MCTP1S led to a 
reduced endocytosis of recyclable PM (reduced endocytosis of Tf). It is noticed 
that the dysfunction of ferlin also impair RE trafficking and both Myoferlin and 
Fer1L5 interact with endocytic recycling proteins EDH1 and EDH2 (Doherty et 
al., 2008; Posey et al., 2011). This again enhanced our argument that MCTP1 and 
Ferlins are functionally similar. However, it is highly possible that MCTP1 is 
more involved in the initial RE retrieval process rather than the following 
trafficking process of RE since the time needed for trafficking the internalized Tf 
to perinuclear RE and then recycling back out of cell was not affected by 
MCTP1S overexpression (Fig. 3-16). This might be related to high Ca2+ binding 
properties of MCTP1 C2 domains (Li et al., 1995). Syt III and Syt VII, which 
have high Ca2+ binding affinities, also show activity mainly on PM (Sugita et al., 
2001; Sugita et al., 2002).  
Secretory vesicle retrieval is a special type of endocytosis. It is a complex process 
and shows high heterogeneity (Gandhi & Stevens, 2003; Wu, 2004; Wu et al., 
2007; Smith et al., 2008; Shupliakov & Brodin, 2010). Consistent with the effect 
on RE retrieval from PM, overexpression of MCTP1S also led to a retardation of 
the retrieval of secretory vesicles from PM. This finding suggested that MCTP1 
might regulate SV biogenesis and/or presynaptic plasticity. The retardation of 
secretory vesicle retrieval might have different effects on neurotransmitter release. 





in a prolonged stimulation and thus weaken neurotransmitter release, because 
following exocytosis the rate of recovery of neurotransmitter release is 
determined by vesicle retrieval from the PM and by recruitment of vesicles from 
reserve pools within the synapse. On the other hand, SV retrieval retardation can 
also enhance the neurotransmitter release in a short stimulation by prolonging the 
fusion between SV and PM. Recent studies also found that SV exocytosis and 
endocytosis are actually molecularly coupled, which means the kinetics of 
exocytosis is regulated by endocytosis machineries (Takamori et al., 2006; Balaji 
& Ryan, 2007). This is true regarding the early findings that Syt I was also found 
to regulate SV recycling (Jorgensen et al., 1995) and the C2B domain of Syt I is 
also found to interact with proteins involved in endocytosis (Haucke & De 
Camilli, 1999; Slepnev & De Camilli, 2000). In the process of secretory vesicle 
retrieval, whether MCTP1 serve as a localized Ca2+ buffering molecule or it 
underwent a conformational change or association/dissociation with its potential 
binding partners in response to the Ca2+ signal might be a focus of future studies.  
5. Role of MCTP1 in exocytosis 
Proteins which show high structural similarities with MCTP1, Syt and Ferlin, 
have been extensively studied in the regulation of SV exocytosis which leads to 
neurotransmitter release. To date, Syt I is the most well-studied calcium sensor in 
neurotransmitter release. During neurotransmitter release, Ca2+ influx through 
Ca2+ channel or intracellular Ca2+ store triggers conformational change of Syt I 
and then rapid zippering of SNARE complex, forcing vesicle membrane to fuse 
with PM (Sudhof, 2008). However, it is found that synaptic transmission persists 
in Syt mutants of Drosophila ((DiAntonio et al., 1993) and C. elegans (Nonet et 
al., 1993), which means that many calcium sensors work together to orchestrate 
neurotransmitter exocytosis (Walter et al., 2011) in the nervous system. The 
structural feature of MCTP1 and its localization on SV raised the possibility that 
MCTP1 might also be involved in neurotransmitter exocytosis. Since there are 
numerous types of neurotransmitters in brain  and even the same neurotransmitter 





how MCTP1 might be involved in neurotransmitter exocytosis might be quite 
complex. In the nervous system, MCTP1 is expressed in various types of neurons 
which may use different types of neurotransmitters. For instance, MCTP1 is 
expressed in taste buds neurons which use serotonin as neurotransmitter (Huang 
et al., 2005), while MCTP1 is also expressed in glutamatergic granule cells in 
hippocampus and cholinergic motor neurons. Among these neurotransmitters, we 
focus our study on glutamate release since glutamatergic transmission is deeply 
involved in mood disorders, like depression and anxiety (Tordera et al., 2007). In 
addition, glutamate is widely used as major excitatory neurotransmitter by limbic 
system and most monoaminergic neurons receive glutamatergic innervation, the 
imbalance of glutamate transmission will certainly affect the emotion information 
processing. However, we found MCTP1S overexpression has no significant effect 
on glutamate release in SHSY5Y cells either with or without high K+ stimulation. 
This observation is not surprising since this is the same as what is found about 
Syp. Syp is abundantly and specifically localized on presynaptic vesicles and 
show good colocalization with MCTP1 both in vitro and in vivo (Fig. 3-10). The 
effect of Syp on neurotransmitter exocytosis is still under debate (Valtorta et al., 
2004). Our finding may indicate that MCTP1’s main function might not be 
regulating the SV exocytosis. However, this observation of no effect of MCTP1 
on glutamate release might also be because of the intrinsic difference between 
neuronal cell lines and mature neurons. Furthermore, MCTP1 might be involved 
in release of other neurotransmitters than glutamate, or in other mode of 
exocytosis than high K+ stimulated exocytosis. Therefore, we cannot rule out the 
involvement of MCTP1 in neurotransmitter exocytosis without further studies.          
Besides neurons, MCTP1 is also highly expressed in other types of cells which 
are actively involved in endocytosis and exocytosis. In blood, MCTP1 is highly 
expressed in granulocytes which are actively involved in cytokine and cytotoxic 
molecule secretion. WBC, which include monocytes, lymphocytes, neutrophils, 
eosinophils and basophils (Petryshen et al., 2005), are the first line effector cells 
of innate immunity. It is interesting that MCTP1 is only highly expressed in blood 





granulocytes show high complexity. For instance, there are at least four types of 
granules, including azurophilic granules, specific granules, tertiary granules and 
secretory granules, inside neutrophils. Since the characteristics of the granules 
with bright MCTP1 staining in granulocytes are not determined in the present 
study, whether MCTP1 is involved in endocytosis or exocytosis in blood 
granulocytes is still unknown. Interestingly, MCTP1 expression is not observed in 
monocytes in blood but observed in macrophages in spleen. Macrophages in 
spleen are the cells responsible for cleaning up unwanted cell debris. They are 
derived from monocytes in blood. It is possible that MCTP1 is only expressed in 
activated macrophages since the monocytes in blood are not activated but just 
transporting to their target tissues. In addition, the secretion of tumor necrosis 
factor α (TNFα) (Murray et al., 2005) and pro-inflammatory cytokine interleukin-
6 (Manderson et al., 2007) in stimulated macrophages is also impaired upon the 
dysfunction of RE, indicating that the secretion in macrophage is tightly coupled 
with endocytosis and RE pathway. It is possible that MCTP1 is involved in 
macrophage secretion by affecting the function of RE. Since microglia is an 
analog of macrophage in brain, whether MCTP1 dysfunction in RE pathway can 
affect the secretion from activated microglia and interfere the pathogenesis of 
neurodegenerative disorders is intriguing. However, we did not find conspicuous 
expression of MCTP1 in microglia in normal brain. Whether MCTP1 is expressed 
in activated microglia under pathological condition is still to be addressed in the 
future. 
6. Role of MCTP1 in neuronal migration  
Besides secretory vesicle retrieval, MCTP1 might also be involved in diverse 
cellular activities by regulating the PM internalization or trafficking of various RE 
cargoes (Ohno, 2006). Our study found that MCTP1L overexpression retarded 
neuronal cell migration. In fact, cell migration is tightly controlled by RE 
trafficking. Other multiple C2 domain proteins have already been found to be 
important in cell migration. For example, Dysferlin was observed to be involved 





(Sharma et al., 2010). The recycling of N-cadherin, for example, is critical for 
neuron migration (Kawauchi et al., 2010). It is possible that overexpression of 
MCTP1L leads to a reduced recycling of N-cadherin, which decrease the mobility 
of the host cell. Given the observation that MCTP1 is expressed in neurons during 
brain development (Fig. 3-8), MCTP1 might exert a role in neuron migration and 
formation of layered brain architecture.  
7. Role of MCTP1 in the protection against oxidative stress 
Oxidative stress may lead to neuronal damage. Several recent reports have 
indicated that ROS are deeply involved in the pathophysiology of several 
neurodegenerative diseases, such as AD (Perry et al., 2002) and PD (Jenner, 
2003). The present study revealed a moderate decrease of ROS levels in MCTP1 
transfected PC12 cells. This protective role of MCTP1 was even more prominent 
when cells were subjected to glutamate toxicity. Besides its physiological 
function in neuronal transmission, glutamate may exert its neurotoxicity effect by 
over stimulating its receptors and result in an overload of intracellular Ca2+ which 
lead to mitochondrial calcium overload and the production of ROS (Pereira & 
Oliveira, 1997; Sun et al., 2010);(Starkov et al., 2004; Nicholls, 2009). Since 
MCTP1 possesses three C2 domains which have high binding affinity with Ca2+, 
it is possible that MCTP1 protect cell from glutamate induced oxidative stress by 
buffering the elevated intracellular Ca2+. MCTP1 might also regulate the 
recycling of neuronal glutamate transporter, like EAAT3. Previous studies have 
already found that constitutive active Rab11 (Rab11Q70L) reduced oxidative 
stress, probably through regulating the RE-dependent transport of EAAT3. 
Further studies on the effect of MCTP1 on glutamate receptor recycling, 
intracellular Ca2+ concentration and/or other oxidative pathways may give us 
more clues on this issue.   






























To conclude, current study has found that MCTP1, including MCTP1L and 
MCTP1S, is expressed in rat CNS. MCTP1S is the major isoform expressed in rat 
CNS. This protein is mainly expressed in neurons and shows no obvious 
expression in astrocytes, oligodendrocytes and microglia. Regarding the regional 
distribution of MCTP1 in rat brain, MCTP1 show particularly high expression in 
emotional information processing brain regions, including PFC, CPu, 
hippocampal formation, hebanula, and amygdala. MCTP1 is also highly 
expressed in several motor neuron groups, including superior colliculum-
parabigeminal nucleus, trochlear nucleus, facial motor nucleus, and motor 
neurons in spinal cord ventral horn.     
During brain development, MCTP1 was mainly detected in CP zone, which 
consists of differentiated neurons. Brain regions with earliest synaptogenesis 
show earliest MCTP1 expression. MCTP1 expression show dramatic increase 
when neurons are undergoing peak synaptogenesis.  
Subcellularly, MCTP1 is localized in the presynaptic terminal of mature neuron, 
showing good colocalization with Syp. IEM images also show that MCTP1 
concentrate on the membrane of presynaptic vesicles. In PC12 cells, 
overexpressed MCTP1S colocalized with SLMV marker VAChT, endocytic 
recycling pathway marker Rab5, Rab11, and TfR, but not LDCV marker NPY, 
indicating MCTP1S is associated with SLMV pathway and endocytic recycling 
pathway.  
Functionally, MCTP1S overexpression reduced the endocytosis of Tf488 and 
retarded secretory vesicle retrieval. However, MCTP1S overexpression did not 
affect glutamate release from SHSY5Y cells. Additionally, MCTP1 
overexpression also slowed down neuronal cell migration and protected PC12 
cells from glutamate induced oxidative insult.  
2. Future study 




1. Further decipher the association between MCTP family and neuropsychiatric 
diseases.  
MCTP1 and MCTP2 genes have been implicated in susceptibilities to various 
neuropsychiatric diseases in previous publications (Scott et al., 2009; Djurovic et 
al., 2009). In our present study, we found substantial MCTP1 expression in 
neurons in various brain regions which are implicated in emotional functions, 
which enhance the possible involvement of Mctp in neuropsychiatric diseases. 
However, direct and strong evidence showing the association between MCTPs 
and neuropsychiatric diseases are still not available. Future studies of MCTP 
mRNAs/proteins levels, cell type specificity, and/or splice variations in 
neuropsychiatric patients will give us critical information in this aspect. Post 
mortem brain tissue or blood samples from BD/schizophrenia patients and normal 
control individuals might be collected and analyzed to check for possible 
abnormal expression of MCTPs. Besides human patient samples, Mctp knockout 
mouse might also be a good model to investigate the association between Mctp 
and neuropsychiatric diseases.     
2. Identify MCTP1 interaction proteins.  
The present study has revealed that the protein structure and subcellular 
localization of MCTP1 share many similarities with other membrane anchored 
multiple C2 domain proteins, like Syt and Ferlins. Numerous proteins involved in 
either secretory pathways or endocytic recycling pathways have been proved to 
interact with Syt and Ferlins. These protein-protein interactions are critical for Syt 
and Ferlins to carry out their functions. However, no protein binding partners 
have been identified for Mctps so far. Future studies which investigate the 
potential binding partners of Mctps will greatly clarify the action mechanisms and 
the regulation pathways of Mctps. 
3. Investigate MCTP1 role in neurotransmitter release and SV retrieval.   
In the present study, we found MCTP1 localized on presynaptic vesicles in 
mature neurons and colocalized with SLMV membrane protein VAChT in PC12 




cells. However, no effect of MCTP1S on glutamate release has been found by 
using overexpression method. More studies are needed to clarify whether MCTP1 
plays a role in transmitter release. These investigations may detect multiple 
neurotransmitters, like acetylcholine, DA, and glutamate, and use different 
stimulation protocols to study different modes of neurotransmitter release. In 
addition, MCTP1 knockdown experiment might be helpful to answer this question.    
Although current study has shown MCTP1S overexpression retarded secretory 
vesicle retrieval, whether this retardation can result in a delay of SV replacement 
or decrease of SV genesis is unknown. Since synaptic vesicle refilling is critical 
for presynaptic plasticity and essential to sustain synaptic transmission, it is 
tempting to investigate whether MCTP1 dysfunction would affect presynaptic 
vesicle genesis or refilling in future studies.         
4. Elucidate the mechanism of MCTP1’s protective role against oxidative stress. 
The present study revealed an important role of MCTP1 in the protection against 
oxidative stress. This finding is very intriguing since oxidative stress induced cell 
death is widely involved in various neurodegenerative diseases and psychiatric 
diseases. However, the mechanism of MCTP1’s protective role against oxidative 
stress has not been studied yet. Future studies may focus on the potential signaling 
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